
















Mechanisms of regulation of 






for the award of the degree 
“Doctor of Philosophy” 
of the Georg-August-Universität Göttingen 
within the doctoral program Molecular Biology of Cells 




Renata Lopes Familiar Couto 





Members of the Thesis Committee 
Dr. Nuno Raimundo (1st reviewer) 
Department of Cellular Biochemistry 
University Medical Center Göttingen 
 
Prof. Dr. Blanche Schwappach-Pignataro (2nd reviewer) 
Department of Molecular Biology 
University Medical Center Göttingen 
 
Dr. Alexander Stein 
Membrane Protein Biochemistry Group 
Max Planck Institute for Biophysical Chemistry  
 
 
Further members of the Examination Board 
Dr. Ira Milosevic 
Synaptic Vesicle Dynamics Group 
European Neuroscience Institute Göttingen 
 
Prof. Dr. Silvio Rizzolli 
Department of Neuro- and Sensory Physiology 
University Medical Center Göttingen 
 
Prof. Dr. Doerthe Katschinski 
Institute of Cardiovascular Physiology 












I hereby declare that the dissertation, entitled ‘Mechanisms of regulation of mitochondria-
endoplasmic reticulum contact sites', was written independently and with no other aids or sources 
than quoted.  
 
 
Renata Couto  








































“O Homem é do tamanho do seu sonho.”  














“Nothing in life is to be feared, it is only to be understood. Now is the time to understand 









First of all, I would like to thank my supervisor, Dr. Nuno Raimundo, for giving me this great 
opportunity with a challenging and exciting project. I thank him for all the support and motivation 
during all this time. 
To the members of my thesis committee, Prof. Dr. Blanche Schwappach-Pignataro and Dr. 
Alexander Stein, I thank their participation in my Ph.D. thesis, their suggestions and advices, and 
for the overall support. Also, I would like to thank the further members of my examination board, 
Dr. Ira Milosevic, Prof. Dr. Silvio Rizzolli and Prof. Dr. Doerthe Katschinski, for their time and support. 
I also would like to thank all the collaborators who contributed for this project. 
 
To all present and past members from Raimundo and Milosevic labs, I would like to thank for all 
the support along these years, either science or social related and for the great environment in the 
lab. I am very grateful to King for all experimental support, meaningful discussions, as well as for 
the proofreading of this thesis. I also would like to give a special thank you to Sindhu for the great 
advices and the help in experiments along my work. 
 
This long way allowed me to make new friends, to strengthen some others or even lose some, but 
one thing I am sure, every single person that cross my way during this time contributed for the 
dream become true, even with the smallest thing! And to them I would like to thank for all the 
support and motivation, for taking care of me when I needed the most and for all the great 
moments we had. For you Maria, Cátia, Sílvia, Floriane and Anita thank you for your friendship and 
for your lovely presence in my life. 
 
Por último e mais importante, agradeço às pessoas mais importantes da minha vida, os meus pais 
e o meu tão adorado irmão. É a eles que tenho a agradecer toda a força e apoio incondicional que 
me deram para concluir mais uma etapa na minha vida. Com eles ao meu lado e a motivação que 
me dão, acredito que todos os sonhos e desafios são alcançáveis. Obrigada meus pais por tão bem 
me ensinarem o quanto devemos lutar pelos nossos sonhos e nunca desistir por mais difícil que o 
caminho seja. A vós que sempre acreditastes que seria possível, dedico este trabalho, tornando-o 
nosso. 
 
“One, remember to look up at the stars and not down at your feet. Two, never give up work. Work 
gives you meaning and purpose, and life is empty without it. Three, if you are lucky enough to find 
love, remember it is there and don't throw it away. “- Stephen Hawking 
 VI 
Table of contents 
DECLARATION ............................................................................................................................................ III 
ACKNOWLEDGMENTS ................................................................................................................................. V 
TABLE OF CONTENTS .................................................................................................................................. VI 
LIST OF FIGURES ....................................................................................................................................... VIII 
LIST OF TABLES .......................................................................................................................................... IX 
LIST OF ABBREVIATIONS ............................................................................................................................. X 
ABSTRACT ................................................................................................................................................... 1 
INTRODUCTION .......................................................................................................................................... 3 
MITOCHONDRIA ................................................................................................................................................ 3 
Mitochondrial Structure and function ...................................................................................................... 3 
Mitochondrial metabolism ....................................................................................................................... 4 
Glycolysis .............................................................................................................................................................. 4 
Tricarboxylic acid cycle ......................................................................................................................................... 5 
The respiratory chain and oxidative phosphorylation .......................................................................................... 6 
Mitochondrial dynamics .......................................................................................................................... 7 
Mitochondria and signaling pathways .................................................................................................... 9 
ENDOPLASMIC RETICULUM ................................................................................................................................ 13 
Endoplasmic reticulum structure ........................................................................................................... 13 
Functions of endoplasmic reticulum ...................................................................................................... 14 
Protein synthesis and folding ............................................................................................................................. 14 
Calcium homeostasis .......................................................................................................................................... 15 
Lipid synthesis .................................................................................................................................................... 16 
Dynamics of endoplasmic reticulum ...................................................................................................... 16 
ER-organelle contacts ............................................................................................................................ 17 
MITOCHONDRIA-ER CONTACT SITES .................................................................................................................... 18 
MERCs: structure and composition in mammals ................................................................................... 19 
Control of cellular functions by MERCs in mammals .............................................................................. 21 
MERCs and lipid transfer .................................................................................................................................... 21 
MERCs and calcium regulation ........................................................................................................................... 24 
Control of cell physiology by MERCs in mammals .................................................................................. 26 
MERCs and ER stress .......................................................................................................................................... 26 
MERCs in autophagy........................................................................................................................................... 26 
MERCs and organelle dynamics ......................................................................................................................... 27 
Organelle pathology: MERCs in disease ................................................................................................. 28 
Experimental approaches to investigate MERCs .................................................................................... 29 
AIMS OF THIS STUDY ......................................................................................................................................... 32 
MATERIAL AND METHODS ........................................................................................................................ 33 
MATERIAL ...................................................................................................................................................... 33 
Reagents ................................................................................................................................................ 33 
Kits and disposables ............................................................................................................................... 35 
Buffers and solutions.............................................................................................................................. 36 
Antibodies .............................................................................................................................................. 37 
Cell culture materials ............................................................................................................................. 38 
Plasmids ................................................................................................................................................. 39 
Equipment .............................................................................................................................................. 39 
Software ................................................................................................................................................. 40 
METHODS ...................................................................................................................................................... 41 
Cell Culture ............................................................................................................................................. 41 
Cell lines and culture growth conditions ............................................................................................................ 41 
Generation of stable knock down and overexpression cell lines ....................................................................... 41 
Transfection of HeLa RC-kd and mouse embryonic fibroblasts .......................................................................... 42 
 VII 
Material harvesting ............................................................................................................................... 43 
Cells harvesting for total protein ........................................................................................................................ 43 
Subcellular fractionation .................................................................................................................................... 43 
Biochemical procedures ......................................................................................................................... 44 
Preparation of whole cell lysates from adherent cells ....................................................................................... 44 
Protein concentration determination using Bradford assay .............................................................................. 44 
SDS-PAGE and Immunoblotting.......................................................................................................................... 44 
Immunoprecipitation ............................................................................................................................. 45 
Evaluation of oxygen consumption ........................................................................................................ 46 
Flow cytometry ...................................................................................................................................... 47 
Mitochondrial membrane potential ................................................................................................................... 47 
Measurement of mitochondrial superoxide levels............................................................................................. 47 
Immunocytochemistry ........................................................................................................................... 48 
Confocal microscopy and image analysis ............................................................................................... 48 
Electron microscopy and image analysis ............................................................................................... 48 
Mitochondrial calcium measurement .................................................................................................... 49 
Statistical analyses ................................................................................................................................. 50 
RESULTS .................................................................................................................................................... 51 
LOSS OF AMPK ACTIVITY RESULTS IN INCREASED ENDOPLASMIC RETICULUM-MITOCHONDRIA CONTACT SITES .................... 51 
Mitochondrial function is compromised in AMPK defective cells .......................................................... 51 
Absence of AMPK activity enhances ER-mitochondria communication in mouse embryonic fibroblasts
 ............................................................................................................................................................... 56 
Basal mitochondrial calcium is increased in AMPK-DKO MEFs .............................................................. 59 
AMPK MEDIATES REPRESSION OF MERCS VIA MFF .............................................................................................. 61 
MFF is an AMPK target and a mitochondria-ER protein ........................................................................ 61 
Increased number of MERCs in MFF KO cells ......................................................................................... 62 
AMPK-DEPENDENT PHOSPHORYLATION OF MFF REGULATES MERCS ....................................................................... 63 
Phosphomimetic MFF Ser155-Ser172 in AMPK-DKO cells has a gain of function of MFF .......................... 63 
MFF activity normalizes increased MERCs in AMPK-DKO cells .............................................................. 66 
Mitochondrial function is improved with MFF genetic manipulation in AMPK-DKO cells ..................... 67 
ACTIVATION OF AMPK DECREASES MITOCHONDRIA-ER CONTACT SITES ..................................................................... 68 
AMPK activation after acute mitochondrial stress decreases the number of mitochondria-ER contact 
sites ........................................................................................................................................................ 68 
CHRONIC MITOCHONDRIAL RESPIRATORY CHAIN DEFICIENCY RESULTS IN AMPK INHIBITION AND LEADS TO INCREASED 
MITOCHONDRIA-ER CONTACT SITES ..................................................................................................................... 71 
AMPK activity is repressed in a model of chronic mitochondrial stress ................................................. 71 
Increased MERCs in chronic mitochondrial malfunction ........................................................................ 73 
Increased abundance of MERC related proteins in RC-kd ...................................................................... 74 
Mitochondrial calcium (Ca2+) uptake is enhanced in RC-kd cells............................................................ 76 
Mitochondrial function is compromised in NDUFS4 KO cells ................................................................. 77 
Increased MERCs in NDUFS4 KO cell model ........................................................................................... 78 
DISCUSSION .............................................................................................................................................. 81 
CHRONIC AND ACUTE MITOCHONDRIAL DYSFUNCTION DIFFERENTIALLY REGULATE MERCS ............................................. 81 
AMPK SIGNALING IS REGULATED DIFFERENTIALLY IN CHRONIC AND ACUTE MITOCHONDRIAL STRESS ................................. 83 
AMPK NEGATIVELY AFFECTS MERCS FORMATION ................................................................................................. 85 
THE EFFECT OF AMPK ON MERCS REGULATION IS MEDIATED BY MFF ...................................................................... 86 
SUMMARY AND CONCLUSION .................................................................................................................. 89 
REFERENCES .............................................................................................................................................. 91 





List of figures 
FIGURE 1 | MITOCHONDRIAL STRUCTURE ................................................................................................................... 3 
FIGURE 2| MITOCHONDRIAL RESPIRATION AND OXIDATIVE PHOSPHORYLATION. ................................................................. 7 
FIGURE 3| THE DIFFERENT MITOCHONDRIAL-DEPENDENT SIGNALING PATHWAYS.  ............................................................. 10 
FIGURE 4| ENDOPLASMIC RETICULUM MORPHOLOGY. ................................................................................................. 14 
FIGURE 5| ILLUSTRATION OF PROTEINS AND PROTEIN COMPLEXES PRESENT AT ER-MITOCHONDRIA CONTACT SITES (MERCS).. . 21 
FIGURE 6| MITOCHONDRIA-ER CONTACT SITES (MERCS) FUNCTION IN LIPID TRANSFER. ................................................... 22 
FIGURE 7| CALCIUM (CA2+) TRANSFER OCCURS AT MITOCHONDRIA-ER CONTACT SITES (MERCS). ..................................... 25 
FIGURE 8| MITOCHONDRIAL FUNCTION IS COMPROMISED IN A DEFECTIVE AMPK CELL MODEL. .......................................... 52 
FIGURE 9| AMPK-DKO CELLS HAVE LOWER MITOCHONDRIAL MEMBRANE POTENTIAL. ..................................................... 54 
FIGURE 10| MITOSOX FLUORESCENCE IN WT AND AMPK-DKO CELLS, REPRESENTING MITOCHONDRIAL SUPEROXIDE LEVELS. . 55 
FIGURE 11| MITOCHONDRIAL MORPHOLOGY IS NOT ALTERED IN AMPK-DKO. ............................................................... 56 
FIGURE 12| AMPK IS A NEGATIVE REGULATOR OF ER-MITOCHONDRIA CONTACT SITES. .................................................... 57 
FIGURE 13| AMPK -DKO CELLS HAVE LONGER CONTACT SITES THAN WT AMPK CELLS.   ................................................. 58 
FIGURE 14| INCREASED OVERLAP BETWEEN MITOCHONDRIA AND ER IN AMPK-DKOS. .................................................... 59 
FIGURE 15| SCHEMATIC ILLUSTRATION OF THE FRET SENSOR. ...................................................................................... 60 
FIGURE 16| MITOCHONDRIAL CALCIUM IS ENHANCED IN AMPK DKO MEFS.. ................................................................ 60 
FIGURE 17 | MFF IS A MERC-LOCALIZED AMPK TARGET. .......................................................................................... 61 
FIGURE 18| INCREASED NUMBER OF ER-MITOCHONDRIA CONTACT SITES IN MFF-KO MODEL. ........................................... 62 
FIGURE 19| MFF KO CELLS HAVE LONGER CONTACT SITES THAN WT MFF CELLS. ............................................................ 63 
FIGURE 20| INCREASE IN PDRP1 S616 PHOSPHORYLATION IN SD2 MFF MUTANT. ......................................................... 64 
FIGURE 21| MITOCHONDRIAL MORPHOLOGY OF AMPK-DKO EXPRESSING DIFFERENT MFF MUTANTS. ............................... 65 
FIGURE 22| AMPK REGULATES THE NUMBER OF ER-MITOCHONDRIA CONTACT SITES VIA MFF. ......................................... 66 
FIGURE 23| INCREASED EXTENSION OF ER-MITOCHONDRIA CONTACT SITES IN AMPK-DKO EXPRESSING MFF MUTANTS. ....... 67 
FIGURE 24| MITOCHONDRIAL FUNCTION IS ENHANCED IN AMPK-DKO EXPRESSING MFF MUTANTS.. ................................. 68 
FIGURE 25| ACUTE MITOCHONDRIAL STRESS ACTIVATES AMPK SIGNALING. .................................................................... 69 
FIGURE 26| ACUTE MITOCHONDRIAL MALFUNCTION DECREASES THE NUMBER OF ER-MITOCHONDRIA CONTACT SITES.. ........... 70 
FIGURE 27| INCREASING TREND OF MERCS EXTENSION IN ANTIMYCIN A TREATED CELLS.. ................................................. 71 
FIGURE 28| MITOCHONDRIAL FUNCTION IS COMPROMISED IN RC-KD HELA CELLS. ........................................................... 72 
FIGURE 29| INCREASED ER-MITOCHONDRIA CONTACT SITES IN CHRONIC MITOCHONDRIAL DYSFUNCTION. ............................. 73 
FIGURE 30| INCREASED MERC EXTENSION IN CHRONIC MITOCHONDRIAL DYSFUNCTION.. .................................................. 74 
FIGURE 31| INCREASED PROTEIN LEVELS OF TETHERS INVOLVED IN MITOCHONDRIA-ER ASSOCIATIONS IN A RC-KD MODEL. ...... 75 
FIGURE 32| INCREASED INTERACTION OF VAPB-PTPIP51 TETHER COMPLEX IN RC-KD HELA CELLS. ................................... 76 
FIGURE 33| MITOCHONDRIAL CA2+ UPTAKE IS ENHANCED IN RC-KD CELL MODEL.  .......................................................... 77 
FIGURE 34| MITOCHONDRIAL FUNCTION IS COMPROMISED IN NDUFS4 KO MODEL.   ...................................................... 78 
FIGURE 35| INCREASING TREND OF ER-MITOCHONDRIA CONTACT SITES IN NDUFS4 KO CELL MODEL.. ................................ 79 
FIGURE 36| INCREASED LENGTH OF ER IN CONTACT WITH MITOCHONDRIA IN NDUFS4 KO CELL MODEL. . ........................... 80 








List of tables 
TABLE 1| LIST OF REAGENTS, THEIR SUPPLIERS AND CATALOG NUMBERS. ......................................................................... 33 
TABLE 2| LIST OF KITS AND DISPOSABLES USED IN THE STUDY. ....................................................................................... 35 
TABLE 3| LIST OF BUFFERS AND SOLUTIONS ............................................................................................................... 36 
TABLE 4| PRIMARY ANTIBODIES FOR IMMUNOBLOTTING AND IMMUNOCYTOCHEMISTRY. ................................................... 37 
TABLE 5| SECONDARY ANTIBODIES FOR IMMUNOBLOTTING AND IMMUNOCYTOCHEMISTRY. ............................................... 38 
TABLE 6| CELL CULTURE MATERIALS AND DEVICES....................................................................................................... 38 
TABLE 7| PLASMIDS AND SHRNA USED IN THIS STUDY. ................................................................................................ 39 
TABLE 8 | LIST OF EQUIPMENT. ............................................................................................................................... 39 
















List of abbreviations 
 
m   Mitochondrial membrane potential 
ACBD5   Acyl-coenzyme A binding domain protein 5 
ACC1/2   Acetyl-CoA carboxylase 1 
AD   Alzheimer disease 
ADP   Adenosine diphosphate 
ALS/FTD  Amyotrophic lateral sclerosis/frontotemporal dementia 
AMPK   Adenosine monophosphate-activated protein kinase 
APS   Ammonium Persulfate 
ATP   Adenosine triphosphate 
BAP31   B-cell receptor-associated protein 31 
BSA   Bovine serum albumin 
Ca2+   Calcium 
CICR   Ca2+-induced Ca2+ release 
CLIMP63  63-kDa cytoskeleton-linking membrane protein 
CoA   Coenzyme-A 
Cyt C   Cytochrome C 
DAG   Diacyl-glycerol 
DMEM   Dulbecco´s Modified Eagle´s Medium 
DRP1   Dynamin-related protein 1 
EM   Electron microscopy 
EMC   ER–membrane protein complex 
ER   Endoplasmic Reticulum 
ERAD   ER-associated degradation 
ERMES   ER–mitochondria encounter structure 
ERRS   Estrogens-related receptors 
ETC   Electron transport chain  
FBS   Fetal Bovine Serum 
FCCP   Carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone 
Fis1   Fission 1 
FRET   Förster/Fluorescence resonance energy transfer  
GFP   Green fluorescent protein 
GPCR   G protein-coupled receptor 
GRP75   Glucose related regulated protein 75 
 XI 
H2O2   Hydrogen peroxide 
IDH   Isocitrate dehydrogenase 
IMM   Inner mitochondrial membrane 
IMS   Inner mitochondrial space 
IP3   Inositol 1,4,5-triphosphate 
IP3R   Inositol-1,4,5-triphosphate receptor 
LTPs   Lipid transfer proteins 
MAMs   Mitochondria-associated membranes 
MCU   Mitochondrial Ca2+ uniporter 
MERCs   Mitochondria-ER contact sites 
MFF   Mitochondrial fission factor 
MFN1/2  Mitofusin1/2 
MID   Mitochondrial dynamics proteins 
MitoUPR   Mitochondrial unfolded protein response 
mPTP   Mitochondrial permeability transition pore 
mPTP   Mitochondrial permeability transition pore 
mtDNA   Mitochondrial DNA 
O2    Oxygen 
O2-   Superoxide anion 
OCR   Oxygen consumption rate 
OMM   Outer mitochondrial membrane 
OPA1   Optic atrophy 1 
ORP   Oxysterol-binding protein (OSBP)-related proteins 
OSBP   Oxysterol-binding protein (OSBP 
OsO4   Osmium tetroxide 
PACS2   Phosphofurin acidic cluster sorting protein 2 
PC   Phosphatidylcholine 
PD   Parkinson’s disease 
PDH   Pyruvate dehydrogenase 
PE   Phosphatidylethanolamine  
PGC1   Peroxisome proliferator-activated receptor- co-activator 1 
PIP2   Phosphatidylinositol 4,5 biphosphate 
PLA   Proximity ligation assay 
PLC   Phospholipase C 
PM   Plasma membrane 
 XII 
PPAR   Peroxisome proliferator-activated receptor- 
PS   Phosphatidylserine 
PSS   PS synthase 
PTPIP51  Protein tyrosine phosphatase interacting protein 51 
Q   Ubiquinone 
ROS   Reactive Oxygen Species 
RRBP1   Ribosome-binding protein 1 
rRNAs   Ribosomal ribonucleic acids 
Rtn4a   Reticulon 4a 
RyRs   Ryanodine receptors 
SERCA   Sarcoendoplasmic reticulum Ca2+-ATPase 
Sig-1R   Sigma-1 receptor 
SMP   Synaptotagmin-like Mitochondrial lipid-binding 
SOCE   Store-operated Ca2+ entry 
SOD2   Superoxide dismutase 2 
SRP   Signal recognition particle 
STIM1   Stromal interaction molecule 1 
SYNJ2BP  Synaptojanin-2 binding protein 
TAC   Tip attachment complex 
TCA   Tricarboxylic acid 
TDP-43   Tar DNA-binding proteins-43 
TEM   Transmission electron microscopy    
tRNAs   Transfer ribonucleic acids 
UA   Uranyl acetate 
UPR   Unfolded protein response 
VAPB   Vesicle-associated membrane protein-associated protein B 
VDAC   Voltage-dependent anion channel  
VPS13A   Vacuolar protein sorting-associated protein 
 
  1 
ABSTRACT 
In eukaryotic cells, inter-organelle communication is crucial for several cellular functions, as well as 
for several cell signaling mechanisms. Mitochondria and the endoplasmic reticulum (ER), for 
example, form tight contact sites that are implicated in many aspects of cell physiology, and whose 
disruption has been associated with pathology, particularly neurodegenerative diseases. Although 
the contacts between these organelles are one of the most studied and most stable, the basic 
understanding of their regulation, as well as the communication of these two organelles via 
signaling pathways remains unclear. 
  
Here, we explored the regulatory environment of the mitochondria-ER contact sites (MERCs) in 
various mammalian cells with mitochondrial malfunction. To identify the mechanisms regulating 
mitochondria and ER crosstalk, we used cellular models of acute and chronic mitochondrial 
dysfunction, which were generated by chemical inhibition of the respiratory chain and by silencing 
the expression of UQCRC1 in HeLa cells or preparing murine embryonic fibroblasts from the Ndufs4 
KO mouse. 
 
Interestingly, we found distinct effects of mitochondrial malfunction on MERCs formation 
depending on whether the mitochondrial defect was acute or chronic. Electron microscopy (EM) 
analysis showed a high number of MERCs in both UQCRC1 KD and Ndufs4 KO models of chronic 
mitochondrial malfunction. Opposed to these data, acute mitochondrial stress seems to repress 
MERCs formation, since fewer contact sites were observed. Importantly, we found differential 
response of AMPK to chronic and acute mitochondrial dysfunction, which negatively correlated 
with MERCs formation. Indeed, while chronic mitochondrial malfunction resulted in the repression 
of AMPK, acute mitochondrial stress activated AMPK signaling. Consistently, in AMPK depleted 
cells, EM and confocal analyses confirmed the increased mitochondria-ER juxtaposition, which was 
observed in the chronic mitochondrial malfunction models.  
  
We also identified mitochondrial fission factor (MFF), which is involved in mitochondrial fission, as 
an AMPK target that localized to the MERCs. Indeed, we showed that MFF is involved in the 
regulation of MERCs, since a robust increase in the number of MERCs was observed in cells lacking 
MFF. Furthermore, a phospho-mimetic isoform of MFF normalized the number of MERCs to WT 
levels in cells lacking AMPK activity, suggesting that AMPK mediates the repression of 




Taken together, our data identified a cellular signaling pathway downstream of a key kinase, AMPK 
that regulates the number of MERCs by modulating MFF activity. Moreover, our results highlight 
that the association of mitochondria with ER is yet another aspect of mitochondrial biology under 
the control of AMPK. This study contributed to a better understanding of MERCs by elucidating 
their response to mitochondrial respiratory chain malfunction in a defined manner, thereby 







1.1. Mitochondria  
1.1.1. Mitochondrial Structure and function 
In eukaryotic cells, the mitochondrion is the organelle responsible for aerobic respiration. This 
organelle is a double membrane-enclosed sub-compartment of the cell, which uses oxygen to 
produce energy, in the form of Adenosine triphosphate (ATP), and thus has been considered for 
many years as the “powerhouse” of the cells. The mitochondrion is an example of endosymbiont 
from the endosymbiosis theory, which defends that the inner mitochondrial membrane (IMM) and 
their content is derived from an ancestral bacteria (Sagan, 1967). In fact, it was discovered that 
these organelles carry their own DNA (mtDNA). The mitochondrial genome codes 37 genes 
comprising 13 proteins linked to respiratory chain complexes, 2 ribosomal RNAs (rRNAs) and 22 
transfer RNAs (tRNAs). Mitochondria have a very complex ultrastructure, composed of two distinct 












Figure 1 | Mitochondrial structure. Scheme of a mitochondrion showing the outer mitochondrial membrane 
(OMM) surrounding the intermembrane space (IMS) and inner mitochondrial membrane (IMM). The folding of 
IMM generates the cristae, which encloses the mitochondrial matrix, where the respiratory chain complexes 
and mtDNA are located. 
 
The OMM acts as a barrier between the cytoplasm and the intermembrane space (IMS). This barrier 
is important to avoid the entry of small molecules, as well as to protect against some deleterious 
mitochondrial factors, such pro-apoptotic factors. In addition, voltage-dependent anion channel 
(VDAC) is located at the OMM, and is responsible for the entrance of some ions (e.g. Ca2+) 




The respiratory chain complexes and carriers for metabolites are located in the IMM. An important 
characteristic of this membrane is the presence of cardiolipin, a required phospholipid for optimal 
mitochondrial respiratory chain performance. Moreover, IMM is recognized by the presence of 
invaginations, called cristae (Figure 1). The cristae are the key structural components in the 
mitochondria, in which the respiratory chain and the OXPHOS machinery are located. The 
mitochondrial matrix is where processes involved in mitochondrial metabolism, and maintenance, 
replication, transcription and translation of mtDNA occur (Scalettar et al., 1991).  
 
Besides ATP production, mitochondria have been also associated with essential cellular functions, 
such as amino acid and fatty acid metabolism, iron-sulfur cluster biogenesis, heme and steroid 
synthesis, and calcium homeostasis (Nunnari and Suomalainen, 2012). Mitochondria are also 
involved in the regulation of cellular processes, like autophagy and apoptosis, cell proliferation and 
differentiation (Nunnari and Suomalainen, 2012; Raimundo, 2014). Due to the pivotal importance 
of mitochondria in cellular physiology, mitochondrial malfunction is implicated in several 
pathologies (DiMauro and Schon, 2008). For instance, it has been shown that defects in genes 
encoding mitochondrial proteins result in disease, including myopathies and neurodegenerative 
diseases (DiMauro and Schon, 2008). 
 
 
1.1.2. Mitochondrial metabolism  
In eukaryotic cells, most of the energy is derived from oxidation of carbohydrates and fatty acids in 
mitochondria because the oxidation of glucose via glycolysis is not so efficient. Therefore, several 
metabolic pathways take place in mitochondria, where enzymes located in the IMM or the matrix 
are involved.  
 
 
1.1.2.1. Glycolysis  
Glycolysis is the process in which glucose is oxidized to pyruvate, and cytosolic enzymes are 
responsible for this process. The pathway is composed of 10 reactions, and it generates pyruvate 
and NADH in the cytosol. Two net ATP molecules per glucose molecule are generated in this 
metabolic pathway. The pyruvate generated can then enter into the mitochondrial matrix under 
aerobic conditions, where is metabolized to acetyl-Coenzyme A (CoA), thus feeding the tricarboxylic 
acid (TCA) cycle and the downstream aerobic metabolism. However, in the absence of oxygen (O2), 




1.1.2.2. Tricarboxylic acid cycle 
Franz Koop and Carl Martinus made some of the first contributions to the discovery of the TCA 
cycle, where they found a reaction to form citrate from oxaloacetate. However, it was in 1937 that 
Hans Krebs and William Johnson discovered the reaction sequence of the TCA cycle, from citrate 
oxidation to oxaloacetate. In addition, they proposed a two-carbon donor, which allowed the 
conversion of oxaloacetate to citrate (Krebs and Johnson, 1937). The TCA cycle occurs in the 
mitochondrial matrix, where the enzymes responsible for this pathway are located, with the 
exception of succinate dehydrogenase, which is localized to the matrix side of the IMM.  Acetyl-
CoA is considered the bridge between the end product of glycolysis, pyruvate, and the synthesis of 
citrate; therefore acetyl-CoA is the “initial” substrate of TCA cycle. However, it is also possible to 
obtain acetyl-CoA from other sources, such as beta-oxidation of fatty acids, and from the 
catabolism of the amino acids, lysine, leucine, phenylalanine, tyrosine and tryptophan.  
The pyruvate generated from glycolysis is transported into mitochondria through the pyruvate 
carrier, where it undergoes oxidative decarboxylation by the pyruvate dehydrogenase (PDH) 
complex, resulting in acetyl-CoA as product. The TCA cycle starts by the acetyl-CoA reacting with 
oxaloacetate to form citrate, which is catalyzed by citrate synthase (Stern and Ochoa, 1949; Stern 
et al., 1952). The next reaction is catalyzed by aconitase, which converts citrate to isocitrate. The 
first oxidative decarboxylation of the cycle occurs in the synthesis of α-ketoglutarate from 
isocitrate, and it is catalyzed by isocitrate dehydrogenase (IDH), in which one mole of NAD+  is 
reduced to NADH, and one mole of CO2 is released, per mole of α-ketoglutarate produced (Adler et 
al., 1939; Plaut and S. Sung, 1954). In the next step, there is the conversion of α-ketoglutarate to 
succinyl-CoA, catalyzed by the α-ketoglutarate dehydrogenase complex, resulting in CO2 release, 
and in the reduction of one mole of NAD+ to NADH. It is in this step that the decarboxylation stages 
of the TCA cycle terminate, giving way to the next steps that are characterized by several oxidation 
reactions from succinate in order to recover oxaloacetate. Succinyl-CoA is converted to succinate 
by succinyl-CoA synthetase, generating GTP /ATP and CoA- SH. The sixth reaction of the TCA cycle 
is characterized by the oxidation of succinate to fumarate, and the reduction of FAD to FADH2. This 
reaction is catalyzed by succinate dehydrogenase, also known as complex II of respiratory chain. As 
such, this is a direct contact point between the TCA cycle and the respiratory chain. Fumarate 
hydratase is responsible for the reversible hydration of fumarate to malate. Finally, in the last 
reaction of the TCA cycle, where oxaloacetate is recovered from malate, catalyzed by malate 






1.1.2.3. The respiratory chain and oxidative phosphorylation 
The electron transport chain (ETC), also called mitochondrial respiratory chain, is composed of a 
group of protein complexes present in the IMM, which is also the place where the ATP synthase is 
localized. This is a very efficient pathway that couples ATP generation to the oxidation of NADH and 
FADH2. The ETC consists of complex I, complex II, complex III and complex IV. The complex V, also 
referred to as mitochondrial ATP synthase, consists of a multi-complex structure made of F1 and FO 
subunits, and is able to transform adenosine diphosphate (ADP) to ATP (Mitchell and Moyle, 1969; 
Scheffler, 2008). The ETC is responsible for the electron transfer from electron donors to electron 
acceptors via redox reactions. Additionally, there is pumping of H+ across the IMM, from the matrix 
to the IMS, generating an electrochemical gradient across the IMM, which is required for the 
process of ATP synthesis via oxidative phosphorylation (MITCHELL, 1961). Briefly, in complexes I 
and II, NADH and succinate (FADH2) are oxidized to NAD+ and FAD respectively. The electrons 
released from both complexes are directed to an electron transporter, ubiquinol, which in turn 
carries the electrons to complex III. In complex III, the received electrons are transferred via 
ubiquinone cycle to cytochrome c, the second electron transporter in ETC. Cytochrome c gives the 
electrons to complex IV (cytochrome c oxidase), which are then passed to O2, forming H2O. These 
redox reactions are able to release energy, which is used by complex I, III and IV to pump H+ into 
the IMS. However, these protons are returned to the matrix through ATP synthase (complex V), 
promoting ATP synthesis from the phosphorylation of ADP and Pi (Figure 2) (Scheffler, 2008). 
 
The crucial role of ETC in the cellular metabolism is known, being the major source of ATP 
production. As a result, some compounds which can interfere with the complexes of ETC, inhibiting 
them and consequently impairing the normal functioning of oxidative phosphorylation have been 
described. These compounds are crucial for understanding further the role of the ETC in several 
cellular processes. For instance, complex I can be inhibited by a specific inhibitor, rotenone, 
preventing ubiquinone reduction. However, complex II remains functional, and by transferring 
electrons to complex III, it allows the functioning of the ETC, although to a lower extent of electron 
flow. Antimycin A inhibits complex III, and therefore makes it virtually impossible to transfer 
electrons coming from complexes I and II to the final acceptor, O2. Cyanide is the most potent 
inhibitor of the ETC, and binds irreversibly to complex IV, making it impossible for O2 to bind to 
complex IV. Moreover, there is oligomycin which inhibits the phosphorylation in complex V, 
blocking the F0 subunit of ATP synthase. This inhibition stops the entrance of protons from the IMS 




Other notable compounds are the uncouplers of respiratory chain, for example carbonyl cyanide-
4-(trifluoromethoxy)phenylhydrazone (FCCP), which are fatty acids that are able to associate with 
the protons in the IMS and transport them to the mitochondrial matrix (Kessler et al., 1976; Lou et 
al., 2007). These uncouplers increase the ETC velocity, allowing an increased reduction of O2 to H2O, 
but no ATP is generated due to the dissipation of electrochemical gradient. Thus, these agents 
uncouple the respiratory chain from oxidative phosphorylation (Lou et al., 2007; Terada, 1990).  
 
 
Figure 2 | Mitochondrial respiration and oxidative phosphorylation. The respiratory chain complexes (I-IV), ubiquinone 
(Q), cytochrome c (Cyt c) and ATP synthase (complex V) are located in the inner mitochondrial membrane (IMM). Red 
arrows represent the transfer of electrons between respiratory chain complexes.  
 
 
1.1.3. Mitochondrial dynamics 
Mitochondria are not anymore considered as static, rod-shaped organelles; nowadays they are very 
well known to undergo processes like fusion and fission. These two concepts were already 
discovered in 1914 by Lewis and Lewis, using chick embryo cells in culture (LEWIS and LEWIS, 1914).  
The division of one mitochondrion into two daughter mitochondria is a process called 
mitochondrial fission. On the other hand, mitochondrial fusion is characterized by the union of two 
mitochondria (Tilokani et al., 2018). A balance between fission and fusion is necessary in order to 
regulate mitochondrial morphology, distribution and function (Chan, 2012). Moreover, these 
mitochondrial parameters can change depending on cell type, and on the specific needs of the cell. 




morphology. Therefore, mitochondrial dynamics is essential in mitochondrial quality control (Chan, 
2012; Pernas and Scorrano, 2016). Due to deregulation of these two processes, mitochondria can 
have a fragmented profile, which is characterized by a large number of small round-shape 
mitochondria or a hyperfused network observed as elongated and well connected mitochondria 
(Tilokani et al., 2018). Naturally, some pathological conditions are associated with these different 
mitochondrial morphology profiles (Nunnari and Suomalainen, 2012). 
 
The process of mitochondrial fission requires some proteins and one key player is a member of the 
dynamin superfamily of GTPases, dynamin-related protein 1 (DRP1) (Smirnova et al., 2001). DRP1 
is a cytosolic protein, which during mitochondrial division is recruited to mitochondria by adaptor 
proteins, such as, Fission 1 (FIS1), mitochondrial fission factor (MFF), mitochondrial dynamics 
proteins (MiD) of 49kDa (MiD49) or 51kDa (MiD51) (Gandre-Babbe and van der Bliek, 2008; Losón 
et al., 2013; Palmer et al., 2013). The  recruitment of DRP1 to the OMM allows its oligomerization 
into a ring-like structure contributing to membrane constriction and scission in a GTP-dependent 
manner (Fonseca et al., 2019; Ingerman et al., 2005; Kamerkar et al., 2018; Kraus and Ryan, 2017; 
Labrousse et al., 1999; Yoon et al., 2001). In this process, the recruitment of DRP1 by adaptor 
proteins is essential, due to the inability of DRP1 to bind membrane phospholipids by itself because 
it lacks a PHD domain (Tilokani et al., 2018). Furthermore, it is known that overexpression of MFF 
enhances mitochondrial fragmentation, while mitochondrial elongation following MFF genetic 
silencing has been demonstrated (Otera et al., 2010). Mitochondrial fission is associated with 
cellular processes, such as apoptosis and mitochondrial proliferation during cell division (Chan, 
2012; Pernas and Scorrano, 2016). 
 
Mitochondrial fusion is carried out by mitofusins 1 and 2 (MFN1 and MFN2 respectively) and optic 
atrophy 1 (OPA1). The latter is responsible for IMM fusion, while MFN1 and MFN2 mediate the 
OMM fusion (Pernas and Scorrano, 2016). Therefore, mitochondrial fusion requires two different 
events, OMM and IMM fusion. Indeed, the overexpression of mitofusins is associated with 
mitochondrial aggregation around the nucleus (Eura, 2003). On the other hand, their knockout 
induces severe mitochondrial morphology defects leading to embryonic lethality in mice and 
embryonic fibroblasts (Chen et al., 2003; Davies et al., 2007; Ishihara et al., 2009; Wakabayashi et 
al., 2009).	 
During mitochondrial fusion, MFN1 and MFN2, two large GTPases, tether two closely apposed 
mitochondria by establishing homo or heterotypic complexes in trans between both proteins via 




al., 2011). However, another model of the tethering was proposed recently, in which the proteins 
interact via GTPase domains (Cao et al., 2017; Qi et al., 2016). As a consequence of GTP binding 
and/or hydrolysis, a conformational change of mitofusins occurs, promoting mitochondrial docking. 
Finally, the OMM fusion is ensured by GTPase-dependent power stroke or GTP-dependent 
oligomerization (Tilokani et al., 2018). As mentioned above, IMM fusion is required to complete the 
mitochondrial fusion process, and is mediated by another GTPase, OPA1, and specific lipids present 
in the IMM (Tilokani et al., 2018). It has been demonstrated that OPA1 and cardiolipin interact after 
OMM fusion, contributing to IMM fusion. This interaction allows the tethering of both IMM, which 
in the end fuse as a result of GTP hydrolysis (Ban et al., 2017; Tilokani et al., 2018). Mitochondrial 
fusion has been shown to be essential, improving cell survival due to the ability to form branches 
and interconnected organelles, which in turn allows the exchange of IMS and matrix contents, 
including mtDNA (Gomes et al., 2011a, 2011b; Rambold et al., 2011). 
 
 
1.1.4. Mitochondria and signaling pathways  
Nowadays, it is clear that mitochondria do not only play a role in metabolic functions but also they 
have signaling functions by communicating their biosynthetic and bioenergetic performance to the 
rest of the cell (Chandel, 2014). The idea that mitochondria communicate with the cytosol was 
raised in the 1990s by several groups, and currently, it is well known that mitochondria have several 
mechanisms to communicate their performance. Some examples are the release of metabolites 
and ROS, activation of 5' adenosine monophosphate-activated protein kinase (AMPK), release of 
peptides, as well as changes in inner mitochondrial membrane potential and calcium (Chandel, 
2015). It is possible that all these processes cooperate together, because once mitochondrial 
respiratory chain flux is impaired, several other consequences appear, such as decrease of ATP 
release, and a decline of ROS and TCA cycle metabolites can also be observed (Chandel, 2015; 
Raimundo et al., 2011). Several diseases have been associated with defects of mitochondrial 
metabolism and consequent impairment to generate ATP, causing mitochondrial disorders, 
particularly in cells with high energetic demand, such as neurons or cardiomyocytes. Nevertheless, 
the connection between mitochondrial signaling and mitochondrial impairment is now known. 
Besides the release of cytochrome C from mitochondria to initiate apoptosis or ROS to induce 
hypoxic gene expression (Chandel et al., 2000; Liu et al., 1996; Raimundo, 2014), there are other 
signaling pathways that are able to connect mitochondria to the  cytosol, and to the nucleus, such 
as AMPK signaling, mitochondrial unfolded protein response (mitoUPR) or calcium (Ca2+) release 




Several other mitochondrial-related pathways are known, but only those, which are relevant in the 




Figure 3 | The different mitochondrial-dependent signaling pathways. In eukaryotes, mitochondria have a role in 
signaling pathways, in order to communicate mitochondrial fitness to the rest of the cell. Included in these signaling 
pathways are AMPK activation, release of metabolites and reactive oxygen species (ROS), and also calcium uptake and 
release. Moreover, MAMs are a greater signaling platform. ETC, electron transport chain; TCA, tricarboxylic acid; MAM, 
mitochondria-associated membranes; ER, endoplasmic reticulum. 
 
Mitochondria are one of the sources of ROS in the cells, and they are generated by complexes I and 
III of the respiratory chain (Murphy, 2009). The superoxide anion (O2-) released to the mitochondrial 
matrix and to the IMS is converted to H2O2 by the enzymes superoxide dismutase 2 (SOD2) and 
SOD1, respectively (Murphy, 2009). Nowadays, ROS are not only considered as toxic by-products in 
the cell, but they are also molecules that can regulate signaling pathways from mitochondria to the 
rest of the cell (Murphy, 2009). Indeed, H2O2 can be considered as a good mitochondrial signal since 
it crosses membranes (Han et al., 2003). Furthermore, the role of mitochondrial ROS in the 
regulation of proliferation and differentiation has been shown (Nunnari and Suomalainen, 2012). 
Additionally, a decrease in the activation of signaling pathways required for cell proliferation, 




and Chandel, 2012). Moreover, ROS have been associated with the regulation of cellular adaptation 
to hypoxia, due to release of mitochondrial ROS stimulated by hypoxia conditions (Chandel et al., 
1998). In 2012, Raimundo et al. showed ROS-dependent  activation of AMPK, with consequent 
apoptosis mediated by E2F1 (Raimundo et al., 2012) further highlighting the widespread nature of 
mitochondrial ROS signaling in the cell. 
 
In addition to ROS, AMPK signaling can be activated after a drop in ATP levels, with a concomitant 
increase of AMP levels. This results in a switch from an anabolic to a catabolic process by the 
phosphorylation of key proteins in multiple pathways, including mitochondrial homeostasis (Egan 
et al., 2011a; Herzig and Shaw, 2018; Jager et al., 2007; Toyama et al., 2016). This mechanism is 
considered important for cells to restore cellular energy supply during energy stress.  
One mechanism of AMPK action is the stimulation of the breakdown of macromolecules, such as 
mobilization of lipid stores, to generate energy (Herzig and Shaw, 2018). After stimulation of lipases 
and release of fatty acids from triglyceride stores, free fatty acids are imported into mitochondria 
for b-oxidation (Ahmadian et al., 2011). Moreover, AMPK activity modulates the activity of the 
acetyl transferase, CPT1, which is responsible for the transport of fatty acids into mitochondria 
(Herzig and Shaw, 2018). In addition, acetyl-CoA carboxylase 1 (ACC1) and ACC2, targets of AMPK, 
are able to produce malonyl-CoA, which in turn can inhibit CPT1 (McGarry et al., 1978; Saggerson, 
2008). Therefore, phosphorylation and inhibition of ACC by AMPK contributes to reduced levels of 
malonyl-CoA, promoting fatty acid import to mitochondria for b-oxidation (Herzig and Shaw, 2018). 
Another mechanism of AMPK activity in mitochondrial signaling is the upregulation of genes 
involved in mitochondrial biogenesis, thus controlling mitochondrial number. There are several 
downstream effectors of AMPK that contribute to mitochondrial biogenesis, including peroxisome 
proliferator-activated receptor-g co-activator 1a (PGC1a), which in turn is able to interact with 
peroxisome proliferator-activated receptor-g (PPARg) or estrogen-related receptors (ERRs), thereby 
activating mitochondrial biogenesis (Garcia-Roves et al., 2008; Herzig and Shaw, 2018; Jager et al., 
2007). 
An important aspect of mitochondria biology that AMPK regulates is the shape of the mitochondrial 
network. It is known that mitochondrial insults, including ETC inhibition, are associated with 
mitochondrial fragmentation (Wai and Langer, 2016). Interestingly, these inhibitors of ETC are also 
able to activate AMPK, which was shown to be required for mitochondrial fragmentation after 
rotenone or antimycin A treatment (Toyama et al., 2016). Moreover, in the same study, the 
receptor of DRP1 in the OMM, MFF, was discovered as an AMPK substrate,  responsible for 




Ryan, 2017; Toyama et al., 2016). Additionally, an increase of DRP1 at mitochondria was observed 
after AMPK activation and MFF phosphorylation (Toyama et al., 2016).  
Finally, AMPK is also able to regulate autophagy by regulating some aspects of the autophagy 
machinery in mammalian cells and in yeast (Herzig and Shaw, 2018). It was shown in 2011 that 
AMPK phosphorylates ULK1, an important kinase for autophagy activation (Egan et al., 2011a; Kim 
et al., 2011). Indeed mitochondrial respiratory chain deficiency was recently shown to regulate, 
through AMPK signaling, the biogenesis of lysosomes, which are crucial organelles for the 
autophagic process (Fernández-Mosquera et al., 2017) suggesting that mitochondria play a role in 
the autophagy process via AMPK activation.  
 
An important aspect of mitochondrial signaling is its involvement in Ca2+ signaling. Moreover, ATP 
production is regulated by Ca2+ signaling, since this cation can enter into the mitochondrial matrix 
and regulate proteins, enzymes and transporters, which are involved in ATP production (Rossi et 
al., 2019). Mitochondrial Ca2+ uptake is dependent on the electrochemical gradient across the IMM 
generated by the respiratory chain (Rizzuto et al., 2012). In the OMM, VDAC allows the entrance of 
Ca2+; however, the IMM is impermeable to this cation, requiring specialized channels such as the 
mitochondrial Ca2+ uniporter (MCU), which is responsible for Ca2+ entrance into mitochondria 
(Baughman et al., 2011; De Stefani et al., 2011). Additionally, mitochondria are also able to export 
Ca2+ through the Na+/Ca2+ exchanger (Rossi et al., 2019). 
It is important to note that although mitochondrial Ca2+ can be beneficial, and can regulate 
mitochondrial metabolism, on the other hand, it can also be toxic, especially under conditions of 
high amounts of Ca2+ in the matrix, thus contributing to pathological conditions (Rossi et al., 2019). 
It is very well established that Ca2+ overload is responsible for the induction of cell death by 
apoptosis or necrosis. Mitochondrial Ca2+ in excess is able to open the mitochondrial permeability 
transition pore (mPTP), promoting the release from mitochondria of cytochrome c, which is a pro-












1.2. Endoplasmic reticulum  
1.2.1. Endoplasmic reticulum structure  
In 1945, scientists observed for the first time by electron microscopy a “lace-like” structure in the 
cells. However, it was only in 1952 that Porter and Kallman introduced the term endoplasmic 
reticulum (ER), where the preferential localization of vesicular structures in the perinuclear area of 
the cytoplasm  was observed (Palade, 1956). 
The mammalian ER is characterized by continuous membrane structures, which are organized into 
different subdomains, as nuclear envelope and peripheral ER. The latter subdomain is defined as 
flat sheets and branched tubules, which includes the rough ER and smooth ER, respectively (Figure 
4) (Park and Blackstone, 2010; Schwarz and Blower, 2016). However, in the presence of cellular 
stresses, ER architecture can be modified by several processes, including fusion, fission, elongation 
and membrane degradation (Park and Blackstone, 2010). 
The rough ER is characterized by being enriched in ribosomes, and is responsible for protein 
synthesis, folding and post-translational modifications (Bravo et al., 2013; Schwarz and Blower, 
2016). On the other hand, smooth ER is free of ribosomes and has tubular structures (Bravo et al., 
2013). Moreover, smooth ER is highly dynamic inside the cell due to the ability to fuse, elongate 
and branch (Bravo et al., 2013). Thus, it is clear that tubular ER and sheet ER have different 
characteristics, which can explain the distinct roles in different cellular processes. Therefore, the 
ratio between rough ER and smooth ER can change depending on the cell requirements. An 
example is pancreatic secretory cells, which are known to synthesize a large amount of secreted 
proteins, and thus have higher percentage of sheets (Schwarz and Blower, 2016). However, 
processes associated with lipid synthesis and Ca2+ signaling are related with cells with more tubular 
network, such as adrenal cells (Schwarz and Blower, 2016).  
In the ER, distinct proteins are responsible for the specific shape of ER structures. In the case of 
tubules or sheets with high curvatures, it is clear that the presence of a very-well known group of 
proteins belonging to the reticulon family such as the integral membrane protein Reticulon 4a 
(Rtn4a) is essential (Shibata et al., 2010; Voeltz et al., 2006). Additionally, in mammals DP1 is 
another protein that is able to generate tubules by forming oligomers on the smooth ER (Bravo et 
al., 2013; Shibata et al., 2008). It was shown that overexpression of Rtn4a was able to form more 
tubules, while depletion of Rtn4a and DP1 contributes to peripheral sheets expansion (Shibata et 
al., 2008; Voeltz et al., 2006). Some studies have demonstrated the importance of the ER shape, 
maintenance and proper distribution in several neurological disorders and viral infections, 
suggesting the relevance of ER dynamics in physiology  (Park and Blackstone, 2010; Salinas et al., 



















Figure 4 | Endoplasmic reticulum morphology. Confocal image from wild-type mouse embryonic fibroblasts 
(MEFs) transfected with EGFP-ER marker during 24h. Scale bar 10µm. 
 
 
1.2.2. Functions of endoplasmic reticulum 
The ER  is one of the largest intracellular organelles , and besides being associated with the cellular 
exo-endocytic pathway, it also performs other fundamental roles in the cell, including lipid and 
protein synthesis, Ca2+ homeostasis, as well as in the quality control and degradation of proteins 
(Bravo et al., 2013).  
 
 
1.2.2.1. Protein synthesis and folding 
One of the main functions of the ER is protein synthesis and protein folding (Berridge, 2002). The 
ribosomes play an essential role in this process, by interacting with mRNAs in the cytosol, and 
subsequent docking of this complex, ribosome:mRNA, to the ER membrane. This recruitment to the 
ER membrane occurs via a signal sequence in the newly translated protein, which is recognized and 
bound by the signal recognition particle (SRP) (Walter, 1981a, 1981b). Then, the translation 
recommences when the complex is targeted to the ER membrane for docking to the SRP receptor 




the ones, which will be secreted undergo proper folding and modifications. The process of folding 
is supported by chaperones and folding enzymes, determining the destiny of the secretory proteins 
(Schwarz and Blower, 2016). For the protein secretion process, chaperones are able to release and 
package them for trafficking  to a final destination through the Golgi (van der Zand et al., 2012). 
However, during this process some failures can occur, and proteins do not achieve native and 
functional form, and are misfolded and/or aggregated (Hartl and Hayer-Hartl, 2009). In these 
situations, ER stress response pathways can be activated, including the ER-associated degradation 
(ERAD) mediated by proteasome. This particular mechanism recognizes and clears these abnormal 
proteins, preventing them from entering the secretory pathway (Ruggiano et al., 2014). The 
importance of this pathway is emphasized by reports, which demonstrate that the activation of the 
ER stress response pathways is associated with some pathologies, such as Alzheimer’s disease, 
diabetes and some cancers (Schwarz and Blower, 2016). 
 
 
1.2.2.2. Calcium homeostasis  
Another crucial role of ER is related with Ca2+ homeostasis in the cell, where this organelle is the 
major intracellular Ca2+ store (Eisen, 1985; Jaffe, 1983). The ER has several channels and receptors, 
which are responsible for the release of Ca2+ from the ER to the cytosol, such as ryanodine receptors 
and inositol 1,4,5-triphosphate (IP3) receptors (IP3R) (Clapham, 2005).  
The mechanism of Ca2+ release starts in the plasma membrane (PM) with the stimulation of 
phospholipase C (PLC) by G protein-coupled receptor (GPCR) (Oude Weernink et al., 2007), which 
in turn cleaves phosphatidylinositol 4,5 biphosphate (PIP2) leading to the formation of diacyl-
glycerol (DAG) and IP3. The generated IP3 binds to IP3R present in ER membrane, allowing its 
activation and promoting Ca2+ release to the cytosol (Clapham, 2005). 
Moreover, ryanodine receptors (RyRs), predominantly present in excitable cells, are also Ca2+ 
channels essential for calcium release from the ER to the cytosol. However, their mechanism of 
release is dependent on intracellular Ca2+ levels, also known as the Ca2+-induced Ca2+ release (CICR) 
mechanism (Schwarz and Blower, 2016). Additionally, RyRs can also be activated by dihydropyridine 
receptors, which are voltage-gated channels, and are able to interact with RyRs with subsequent 
Ca2+ release (Fill and Copello, 2002).  
Important to mention is also the entrance of Ca2+ into the ER from the cytosol, which is mainly 
carried out by a Ca2+ pump called Sarcoendoplasmic reticulum Ca2+-ATPase (SERCA) (Clapham, 
2005). In cases of low Ca2+ levels in ER stores, there is activation of a mechanism, which allows Ca2+ 




clear that the ER plays a vital role in intracellular Ca2+ homeostasis, the maintenance of which is 
essential, due to the distinct roles of Ca2+ in several cellular processes and signaling pathways.  
 
 
1.2.2.3. Lipid synthesis  
The biosynthesis of lipids, in particular glycerophospholipids and sphingolipids, mainly occurs in the 
ER (Laplante and Sabatini, 2009). Moreover, the enzymes responsible to transform glycerol and 
fatty acids into triglycerides and diacylglycerol phosphate, the phospholipids precursors, are 
localized in the ER (Bravo et al., 2013). Furthermore, diacylglycerol phosphate is converted into 
DAG, which in turn is converted to phosphatidylcholine (PC) and phosphatidylethanolamine (PE) 
(Bravo et al., 2013). In addition, phosphatidylinositol is also synthesized in the ER, and is essential 
for signaling and vesicle trafficking (Fagone and Jackowski, 2009). The newly synthesized lipids are 
then transported to other organelles and cellular membranes via vesicles of the secretory pathway 
(Van Meer et al., 2008).  
 
 
1.2.3. Dynamics of endoplasmic reticulum 
As mentioned above, the smooth ER is very dynamic and is in constant morphological remodeling. 
In mammalian cells, the important role of microtubules in the ER structure and reorganization is 
known. Indeed, changes in ER shape were observed after treatment with depolymerizing agents 
(Bravo et al., 2013). In fact, in 1986  the requirement of microtubules for the maintenance of ER 
network was already proved (Klopfenstein et al., 1998; Terasaki, 1986). Furthermore, an integral 
protein, 63-kDa cytoskeleton-linking membrane protein (CLIMP63), which helps the interaction 
between ER and microtubules was discovered (Klopfenstein et al., 1998). 
The ER tubule elongation along microtubules is associated with two different mechanisms: tip 
attachment complex (TAC) and ER sliding (Bravo et al., 2013). Briefly, the TAC process involves the 
interaction the ER resident protein, stromal interaction molecule 1 (STIM1) and EB1, a microtubule 
protein. This interaction promotes ER growth depending on microtubules formation (Bravo et al., 
2013; Grigoriev et al., 2008). Regarding ER sliding, two proteins, kinesin 1 and dynein, are 
responsible to pull ER tubules from the ER membrane together with acetylated microtubules 
(Friedman et al., 2010; Wozniak et al., 2009). For some cellular mechanisms, such as differentiation 
or cell division, this interaction between ER and microtubules is crucial for organelle shape 




ER fusion and branching are also processes occurring in the ER, which are crucial for the formation 
of a reticular structure (Anderson and Hetzer, 2007). For this process, the presence of proteins 
called Atlastins, which have GTPase activity, and are able to interact with ER-shaping proteins, 




1.2.4.  ER-organelle contacts  
As mentioned above, the ER is one of the biggest organelles in the cell, contributing to the most of 
membrane contact sites, which have been described in the past years. The ER can have contact 
sites with several other organelles, including Golgi, mitochondria, PM, lipid droplets and 
peroxisomes (Wu et al., 2018). The ER-mitochondria is one of the most well studied contact sites, 
and since it is the main focus of this study, it is discussed in detail in the next section. Another 
contact site that is well known is the connection between ER and PM. It has been reported that the 
distance between ER and PM is approximately 30nm and this communication has been also 
associated with several cellular functions, including calcium regulation, PI metabolism and sterol 
transfer (English and Voeltz, 2013; Schulz and Prinz, 2007; Stefan et al., 2011). In mammals, an 
example of a protein complex, which has been associated with ER-PM contact sites is Stim1 and 
Orai1 present in ER and PM, respectively (Liou et al., 2005, 2007). The low Ca2+ in ER can be detected 
by Stim1, which in turn oligomerizes and interacts with Orai1 on PM, promoting the entrance and 
restoring of Ca2+ in the ER (Liou et al., 2005, 2007). 
Besides, the connection of ER to Golgi apparatus as major components of the secretory pathway,  
has been also described as physical contacts between these two organelles (Bravo et al., 2013). For 
example, ceramides which are produced in the ER are transported to the Golgi in order to be 
converted into sphingomyelin (Hanada et al., 2009; Lev, 2010). Additionally, there is transport of 
phosphatidylinositol and DAG between the organelles by non-vesicular mechanisms, which seems 
to require VAP protein and Nir2 protein for phosphatidylinositol transfer (Peretti et al., 2008). 
Recent studies, also showed an interplay between ER and peroxisomes, which are essentially 
derived from ER membrane, and also share some metabolic functions such as the synthesis of some 
phospholipids (Lodhi and Semenkovich, 2014; Wu et al., 2018). Moreover, it is known that acyl-
coenzyme A binding domain protein 5 (ACBD5) of the peroxisome can interact with VAPs in the ER 
(Costello et al., 2017; Hua et al., 2017). In fact, an increase of number and surface of ER-peroxisome 
contact sites was observed after overexpression of either VAPs or ACBD5 (Costello et al., 2017; Hua 




feature, and there is a membrane continuity between the two organelles (Wu et al., 2018). All the 
examples mentioned have been reported in mammalian cells. However, it is important to mention 
that in other organisms, such as in yeast, more contacts and proteins are known, and some of them 
are conserved, but the machinery to make and keep them is different in eukaryotes (Eisenberg-
Bord et al., 2016).  
 
 
1.3. Mitochondria-ER contact sites 
In all eukaryotic cells, there is a compartmentalization of specific biological and biochemical 
functions in organelles. However, nowadays this idea has further evolved, and we can consider that 
organelles are not isolated and static, and that there is inter-organelle crosstalk. This organelle 
communication is achieved mostly by physical contact between different organelles or through 
signaling mechanism from one organelle to the other.  
The connections between mitochondria and ER were one of the first membrane contact sites 
discovered in 1959 through electron microscopy (Copeland, 1959). Afterwards, several aspects 
about mitochondria-ER contact sites (MERCs) have been discovered.  
Nevertheless, at biochemical level the MERCs were only characterized in 1990 by Jean Vance, when 
she was able to isolate a membrane structure from rat liver, which she defined as the physical 
contact sites between ER and mitochondria (Vance, 1990). Further, functional characterization was 
done but only in the late 1990s when Rizzuto and co-workers showed the role of MERCs on Ca2+ 
transfer between ER and mitochondria through microdomains of high Ca2+ concentrations upon ER 
release (Rizzuto, 1998). Since then, several studies characterizing the function role of MERCs have 
emerged, and it is now known that MERCs play fundamental roles in several aspects of cellular 
function. Moreover, in the past several years, there have been a lot of discoveries regarding the 
MERCs proteome, showing potential proteins associated with MERCs formation and function (De 
Brito and Scorrano, 2008; Cho et al., 2017; Elbaz-Alon et al., 2015; Filadi et al., 2015; Hung et al., 
2017; Simmen et al., 2005; Stoica et al., 2014).  
In this chapter several aspects of MERCs are addressed including the structure and composition, as 
well as the main cellular functions. In addition, mechanistic details of how mitochondria-ER 
communication can impact some pathologies, such as neurodegenerative diseases, cancer and 







1.3.1. MERCs: structure and composition in mammals 
The formation of MERCs is facilitated by the presence of proteins in both organelles, which can 
interact and consequently contribute to the specific properties and functions of MERCs. The 
distance between ER and mitochondria has been reported to be approximately 10 to 25 nm 
(Csordás et al., 2006), which explains how proteins in different organelles can interact, and also the 
importance of MERCs in several cellular functions. For the past years, the list of proteins associated 
with MERCs formation or function has been continuously growing. Recently,  several experts in the 
field have reviewed and discussed the real concepts of contact sites and have classified four types 
of proteins that can be located in the contact sites (Scorrano et al., 2019). The classes can be divided 
as: structural proteins, functional proteins, sorter/recruitment proteins and regulator proteins 
(Scorrano et al., 2019). Structural proteins include tethers, which can hold the two organelles 
together, and spacers that keep both membranes at a defined distance (Scorrano et al., 2019). 
Regarding the functional proteins, these are proteins that support the function of a specific contact 
site, and therefore are located and enriched in those areas. Included in this class are proteins, which 
are able to exchange ions, protein, lipids and metabolites (Scorrano et al., 2019). The contact site 
proteome and lipidome can be defined by sorting and recruitment proteins. Finally, the last class is 
defined by proteins that are able to regulate the extent of the contact sites and the function of the 
active proteins present in this region (Scorrano et al., 2019). 
 
In mammals, one of the protein complexes present in the MERCs is the IP3R-Grp75-VDAC1, which 
has been associated with calcium transfer between both organelles (Rapizzi et al., 2002; Szabadkai 
et al., 2006). The IP3R is one of the receptors located at the ER, and is responsible for  Ca2+ release 
from this organelle to the cytosol (Foskett et al., 2007). However, IP3R interacts with VDAC1 present 
in the mitochondria via glucose related regulated protein 75 (GRP75), therefore the calcium 
released from ER by IP3R is transferred to mitochondria by this interaction in MERCs (Paillusson et 
al., 2016; Rapizzi et al., 2002; Szabadkai et al., 2006). Nevertheless, it is known that complete loss 
of IP3R does not affect the MERCs (Csordás et al., 2006; Paillusson et al., 2016) further illustrating 
the complexity involved in this process.  
Also, the homo- and heterotypic interactions between mitochondrial mitofusin 1/2 and ER-located 
MFN2 have been proposed as a tethering complex (De Brito and Scorrano, 2008). That 
notwithstanding, there are some controversies regarding the real effect of MFN2 on MERCs, since 
studies from different laboratories have shown contradictory results (De Brito and Scorrano, 2008; 
Filadi et al., 2015; Naon et al., 2016). In 2015, Filadi et al. showed in different cell lines that an 




mitochondria. In the end, they proposed a model in which MFN2 works as an antagonist of MERCs, 
avoiding some excessive and toxic proximity between both organelles (Filadi et al., 2015). On the 
other hand, Scorrano`s group has reiterated the role of MFN2 as an agonist of MERCs. In fact, in 
2008 they already showed a disruption of MERCs upon silencing of MFN2 in HeLa cells, thus 
contributing to a reduction on mitochondrial Ca2+ uptake after IP3R stimulation (De Brito and 
Scorrano, 2008). Additionally, these data were re-evaluated in 2016 by Naon et al., due to the 
discrepancies in other studies, and the same results were observed after constitutive or acute 
MFN2 deletion, confirming once again the role of MFN2 as a MERCs tether (Naon et al., 2016).  
Moreover,  localized in the ER there is a vesicle-associated membrane protein-associated protein B 
(VAPB), which was shown to bind to the protein tyrosine phosphatase interacting protein 51 
(PTPIP51), an outer mitochondrial membrane protein (Stoica et al., 2014; De Vos et al., 2012). The 
modulation of this protein complex has been demonstrated to induce alterations in the MERCs and 
consequently affect calcium transfer between the organelles. For example, in a motoneuron-like 
neuroblastoma cell line, the overexpression or silencing of VAPB and PTPIP51 was shown to strongly 
increase or decrease the MERCs, respectively  (Stoica et al., 2014).  
Another complex, formed between the mitochondrial fission protein, Fis1 and BAP31 located at the 
ER, has been implicated in apoptotic functions of  MERCs (Iwasawa et al., 2011). In addition, the 
complex between phosphofurin acidic cluster sorting protein 2 (PACS2) and Bap31 was associated 
with MERCs formation, and with a role in controlling cellular homeostasis and apoptosis (Simmen 
et al., 2005). In 2017, it was shown that a protein located in ER, the PDZ8, which has an orthologous 
Synaptotagmin-like Mitochondrial lipid-binding protein (SMP) domain, also found in yeast, was 
required for MERCs formation as well as mediation of  Ca2+ transfer between the organelles in 
mammalian neurons (Hirabayashi et al., 2017). Moreover, an elegant study from Hung et al. 
discovered a tail-anchored OMM protein, synaptojanin-2 binding protein (SYNJ2BP) using 
peroxidase-mediated proximity biotinylation approach (Hung et al., 2017). They also showed an 
increase of MERCs after overexpression of SYNJ2BP, mediated by interaction with ribosome-
binding protein 1 (RRBP1), which is present in the ER membrane (Hung et al., 2017). In 2018, the 
lab from Pietro De Camilli, reported another human protein present in ER, vacuolar protein sorting-
associated protein 13A (VPS13A), which can tether to mitochondria, contributing to lipid transport 
from ER to mitochondria due to the presence of a hydrophobic cavity in the N-terminal portion of 






Figure 5 | Illustration of proteins and protein complexes present at ER-mitochondria contact sites (MERCs). MFN2, 
mitofusin 2; MFN1, mitofusin 1; MAM, mitochondria-associated membranes; VAPB, vesicle-associated membrane 
protein-associated protein B; PTPIP51, the protein tyrosine phosphatase interacting protein 51; VDAC, voltage-dependent 
anion channel; IP3R, inositol-1,4,5-triphosphate receptor; GRP75, glucose related regulated protein 75; MCU, 
mitochondrial Ca2+ uniporters; PACS2, phosphofurin acidic cluster sorting protein 2. 
 
 
1.3.2. Control of cellular functions by MERCs in mammals 
1.3.2.1. MERCs and lipid transfer 
The biosynthesis of phospholipids is dependent on the crucial functional interplay between ER and 
mitochondria. In the ER there are enzymes which are required for the synthesis of the majority of 
phospholipids (Petrungaro and Kornmann, 2019; Vance and Tasseva, 2013). In mammals, the 
phosphatidylserine (PS) is generated in the ER by the PS synthase (PSS),Which, incidentally, was 
also the first described component of mitochondria-associated membranes (MAMs)(Stone and 
Vance, 2000; Vance, 1990; Vance and Tasseva, 2013). In mitochondria, PS is rapidly converted to 
PE in which a fraction of PE generated is transferred back to the ER, where it is converted to PC or 
further distributed to other cellular membranes (Figure 6) (Petrungaro and Kornmann, 2019). The 
conversion to PC requires the hepatic enzyme PE-N-methyltransferase which is enriched in the 
MERCs (Cui et al., 1993). Taking into consideration this complex interplay, the presence of the close 




aqueous cytosol. Besides, the fact that mitochondria are not connected to the endomembrane 
system via vesicular trafficking, meaning that the lipid transfer is just based on non-vesicular 
transport, makes these contacts more relevant (Petrungaro and Kornmann, 2019).  
 
 
Figure 6 | Mitochondria-ER contact sites (MERCs) function in lipid transfer. In the MERCs, lipids can be transferred 
between both organelles. In the ER membrane phosphatidic acid (PA) is converted to phosphatidylserine (PS), which in 
turn is transferred to inner mitochondrial membrane (IMM). In mitochondria, PS is converted to 
phosphatidylethanolamine (PE) and transferred back to the ER. Part of PE transferred to the ER is converted to 
phosphatidylcholine (PC), which in turn is transported back to mitochondria. Moreover, sterols can also be transferred 
between ER and mitochondria at MERCs. IMM, inner mitochondrial membrane; OMM, outer mitochondrial membrane; 
MAM, mitochondria-associated membranes; PA, phosphatidic acid; PS, phosphatidylserine; PE, 
phosphatidylethanolamine; PC, phosphatidylcholine. 
 
 
The MERCs distance (<30 nm), as well as, the enrichment of lipid-binding proteins and lipid 
synthesizing enzymes in MAMs, provides a good platform for the non-vesicular lipid transport 
(Petrungaro and Kornmann, 2019; Vance, 1990). However, this requires some machinery, for 
example, proteins that are involved in the tethering of both organelles with a role in lipid transport.  
In the past years, several tethers have been proposed in yeast and as well in mammals (Eisenberg-
Bord et al., 2016; Giordano, 2018; Lang et al., 2015; Tamura and Endo, 2017). Moreover, some 
studies show the importance of lipid transfer proteins (LTPs) in the regulation of lipid composition 
of the organelle membranes, thus contributing to the non-vesicular lipid transport at MERCs (Helle 




yeast model, have shown the presence of protein complexes involved in the tethering, as well as in 
lipid trafficking  at MERCs, including ER–mitochondria encounter structure (ERMES) and ER–
membrane protein complex (EMC) (Tamura and Endo, 2017).  In mammalian cells, several proteins 
have been described in the past years, however, none has been shown to be involved in lipid 
trafficking, explaining why is not very well known how lipids can be transferred at MERCs. 
Nevertheless, as mentioned above, the PDZ8 was recently discovered in MERCs, and it was 
considered a good candidate for lipid transfer since it has a mammalian SMP domain (Hirabayashi 
et al., 2017). However, until now, its function on the mitochondrial lipidome has not assessed.  
 
In all eukaryotic membranes, sterols have important roles such as in membrane fluidity, 
permeability and curvature, as well as in membrane protein function (Petrungaro and Kornmann, 
2019). Sterol, once synthesized in the ER, is transported to other organelles, including 
mitochondria. Although in the mitochondrial membranes the amount of sterols is very low,  its 
importance on mitochondrial morphology is well characterized in yeast (Petrungaro and Kornmann, 
2019). Additionally, it is known that in MERCs the cholesterol levels are higher than in the rest of 
the ER, contributing to the idea that MERCs could favor lipid transfer from ER to mitochondria 
(Petrungaro and Kornmann, 2019).  
As mentioned above, LTPs have been closely associated with the non-vesicular transport between 
organelles. Indeed, there are four major families of LTPs which are conserved from yeast to 
mammals, such as oxysterol-binding protein (OSBP)-related proteins (ORP), START, START/VASt, 
and SMP (Petrungaro and Kornmann, 2019). These proteins have been described as tethers, lipid 
sensors, or transporter in contact sites. More recently, some proteins belonging to the ORP and 
Lam/GRAM families, which in fact can be great candidates for mediating lipid transfer, were shown 
in MERCs (Elbaz-Alon et al., 2015; Petrungaro and Kornmann, 2019). In fact, in 2016 the group of 
Francesca Giordano showed that knockdowns of ORP5/ORP8 affect mitochondrial morphology and 
performance, which can be due to the decreased levels of mitochondrial PE (Galmes et al., 2016). 
Recently, a preprint from the same group showed that ORP5/8 are located in MERCs and mediate 
non-vesicular transport of PS between ER and mitochondria by physical and functional interaction 
with MIB/MICOS complexes in mitochondria. However, they also demonstrated a regulation of Ca2+ 








1.3.2.2. MERCs and calcium regulation 
The major Ca2+ store in mammalian cells is the ER, and the release of Ca2+ is through channels 
present in the ER membrane, such as IP3R (Foskett et al., 2007). Once Ca2+ is released into the 
cytosol, it can be taken up into neighboring organelles that require higher levels of Ca2+. In fact, 
several studies show the crucial role of MERCs in intracellular Ca2+ signaling. Due to the close 
proximity between both organelles and the formation of Ca2+ microdomains at MERCs, its transfer 
to mitochondria is direct. Therefore, MERCs have a fundamental role in several aspects of cell 
metabolism and cell fate determination through cellular Ca2+ regulation (Rizzuto et al., 2009). The 
entrance of Ca2+ in mitochondria is dependent on ER Ca2+ release. The IP3R isoform 3 (IP3R3) is 
present in the MERCs and is involved in Ca2+ transfer from ER to mitochondria through physically 
interaction with the mitochondrial VDAC1, present in the OMM. This interaction is facilitated by 
the protein GRP75, which acts as a bridge between IP3R3 and VDAC1 (Figure 7)  (Rapizzi et al., 2002; 
Szabadkai et al., 2006). The IMM is not permeable to Ca2+, however in the IMM there are 
mitochondrial Ca2+ uniporter (MCU), which allow Ca2+ transfer into the mitochondrial matrix 
(Baughman et al., 2011; De Stefani et al., 2011). The low Ca2+ affinity of MCU has already been 
described, therefore higher Ca2+ concentrations at MERCs are required, as well as, an optimal 
distance between the organelles in order to facilitate an efficient Ca2+ delivery to the mitochondrial 
matrix (Csordás et al., 2010; Giacomello et al., 2010; De Stefani et al., 2011). 
The basal Ca2+ transfer between ER and mitochondria via MERCs is crucial to maintain cellular 
bioenergetics (Denton, 2009). It is known that Ca2+ can stimulate the activity of some enzymes in 
the TCA cycle, such as isocitrate and a-ketoglutarate dehydrogenases, as well PDH which connects 
glycolysis with TCA cycle, resulting in more energy production in the cell (Doghman-Bouguerra and 
Lalli, 2019; Rizzuto et al., 2012). Furthermore, mitochondrial ATP synthase can be activated by Ca2+, 
thereby contributing to ATP production (Denton, 2009; Territo et al., 2017). 
More recently, it was also revealed that Ca2+ transfer at MERCs plays a role in the stimulation of 
H2O2 mobilization from mitochondria to MERCs, forming H2O2 domains in these appositions (Booth 
et al., 2016). These H2O2 domains formed can be useful in sustaining cytosolic Ca2+ oscillations by 
targeting IP3R (Booth et al., 2016). 
The efficiency in MERCs calcium exchange is also achieved if  there is an efficient ER Ca2+ storage by 
SERCA, and its modulation by calnexin, an ER chaperone, also determines the capacity of ER to 
release Ca2+ (Lynes et al., 2013). Furthermore, there are other proteins which have been associated 
with mitochondrial Ca2+ uptake, such as Mfn2, PACS-2, Sigma-1 Receptor and Presenilins (Bravo-






















Figure 7 | Calcium (Ca2+) transfer occurs at mitochondria-ER contact sites (MERCs). The Ca2+ released from the ER 
through IP3R is directly transferred to mitochondria by voltage dependent channel 1 (VDAC1) located in the outer 
mitochondrial membrane (OMM). Then, the Ca2+ is transferred into mitochondrial matrix by the mitochondrial Ca2+ 
uniporter (MCU) present in the inner mitochondria membrane (IMM). Once in mitochondria, this cation can activate 
some enzymes related to the TCA cycle, improving the bioenergetics of the cell. The ER lumen is the major Ca2+ store in 
the cell ([Ca2+] of 60-500 µM), and in the mitochondria the Ca2+ concentration can reach 100 µM. 
 
 
The Ca2+ uptake by mitochondria has to be a very well-regulated process, since an excessive Ca2+ 
uptake is also associated with  mitochondrial impairment and apoptosis induction (Pinton et al., 
2008). Mitochondrial Ca2+ overload stimulates apoptosis by activating the mPTP, which in turn leads 
to the dissipation of the mitochondrial potential, mitochondria swelling and consequently the 
release of pro-apoptotic factors, such as cytochrome C (CROMPTON, 1999; Naon and Scorrano, 
2014). Altogether, it is worthy of note that MERCs can have beneficial effects in the cell. On the 
other hand,  prolonged Ca2+ release, in time or too widespread can be detrimental to the cells 







1.3.3. Control of cell physiology by MERCs in mammals 
1.3.3.1. MERCs and ER stress 
The ER is involved in protein folding, which is a crucial process to maintain protein homeostasis and 
thus it is enriched in Ca2+ and several chaperones. For this process, ATP is required for chaperone 
function, as well as for Ca2+ homeostasis. As a result, this is a process with high energy demand. 
However, in some situations, failures in this process can occur, resulting in an inadequate protein 
folding due to failure in the ER machinery. This ER state is called ER stress, in which an accumulation 
of unfolded proteins  occurs (Bravo et al., 2013; van Vliet et al., 2014). 
Importantly, ER also have an adaptive mechanism called the unfolded protein response (UPR), 
which is able to restore ER homeostasis by increasing synthesis of chaperones, degradation of 
misfolded proteins and increasing ER volume (Bravo et al., 2013). It is also important to mention 
that all these alterations are also accompanied with changes in cellular metabolism. Indeed, it has 
been shown that in early phases of ER stress there are changes in ER morphology and redistribution, 
as well as of mitochondrial network towards the perinuclear area of the cell. Additionally, an 
increase of MERCs in this area of the cell was observed (Bravo et al., 2011). All these alterations are 
complemented with pieces of evidence showing an increase in mitochondrial Ca2+ uptake, 
mitochondrial metabolism and ATP production (Bravo et al., 2011). Altogether, this demonstrates 
that reorganization of both organelles, and the increase of MERCs favors cell survival after ER stress 
(Bravo et al., 2011). Furthermore, several studies also show the role of other MERCs components 
on MERCs regulation during ER stress, such as the chaperone sigma-1 receptor (Sig-1R). This 
chaperone was shown to increase Ca2+ transfer and ATP production (Bravo-Sagua et al., 2013; 
Shioda et al., 2012). Additionally, MFN2 seems to be involved in ER stress response, since its amount 




1.3.3.2. MERCs in autophagy  
In eukaryotes, autophagy is responsible for the intracellular quality control. It is a well-studied 
mechanism, which involves the removal and recycling of intracellular content, as well as damaged 
organelles, and ending in lysosomal degradation (Singh and Cuervo, 2011). However, there is 
debate about which membrane contributes to autophagosomes formation, the structural hallmark 
of macroautophagy (Shibutani and Yoshimori, 2014). For some time, it has been known that the ER 




Nevertheless, more recently there were pieces of evidence demonstrating that MERCs were 
involved in the formation of autophagosomes (Hamasaki et al., 2013). Interestingly, a report from 
Hamasaki and colleagues showed the recruitment of ATG14, a pre-autophagosome marker, to the 
MERCs under starvation conditions (Hamasaki et al., 2013) further supporting the role of MERCs in 
autophagosome formation. Consistently, these authors also observed that perturbing the MERCs, 
by interfering with proteins associated with formation of these contact sites, blocks the localization 
of ATG14 at MERCs and consequently prevents the proper formation of autophagosomes 
(Hamasaki et al., 2013). In addition, ATG5, also critical for autophagosome formation, was also 
found in MERCs during phagophore biogenesis (Hamasaki et al., 2013).  
In another study, Rab32, which is required for the formation of autophagic vacuoles (Hirota and 
Tanaka, 2009), it was shown that Rab32 also has a role in the regulation of MERCs properties (Bui 
et al., 2010). Furthermore, PACS2 and MFN2 have been associated with an essential role in 
autophagy regulation since silencing PACS2 and MFN2, which consequently disrupts MERCs 
formation,  was shown to prevent autophagosome formation (Hamasaki et al., 2013). 
Recently, it was also discovered that manipulating VAPB and PTPIP51 expression, by silencing or 
overexpressing, activates or impairs autophagy respectively. These effects are shown to be due to 
their role in Ca2+ exchange between ER and mitochondria (Gomez-Suaga et al., 2017).  
Altogether, these findings support the evidence that MERCs are not only essential for Ca2+ signaling 
or sensing cellular stress but are also crucial for autophagosome formation and supporting a pro-
survival mechanism. Additionally, the recruitment of autophagic machinery at MERCs supports the 




1.3.3.3. MERCs and organelle dynamics 
Mitochondria are very dynamic organelles; always undergoing fission and fusion processes, which 
is crucial in the maintenance of cellular homeostasis (Nunnari and Suomalainen, 2012). The DRP1 
is one of the key players in mitochondrial fission (Kraus and Ryan, 2017; Smirnova et al., 2001). In 
mammalian cells, it is well known that MERCs play a role by marking the constriction sites where 
the fission process will occur (Friedman et al., 2011). In addition, it is recognized that DRP1 spirals 
assemble on mitochondria in these contact points (Friedman et al., 2011). Moreover, it is now 
known that inverted formin-2 in the ER and spire1C present at mitochondria can interact at MERCs. 
This interaction is responsible for actin filament polymerization and elongation, providing force in 




fission occurs (Cohen et al., 2018; Korobova et al., 2013; Manor et al., 2015). In addition, in 2018, a 
role of actin polymerization at MERCs in stimulating  Ca2+ uptake in mitochondria, as well as the 
constriction of IMM was described (Chakrabarti et al., 2018). 
 
 
1.3.4. Organelle pathology: MERCs in disease 
Organelle communication, in particular MERCs, controls several crucial cellular functions such as 
cell bioenergetics, Ca2+ signaling and lipid transport. Therefore, it is expected that alterations in 
MERCs could have wide-ranging effects in cell physiology and consequently culminate in some 
pathologies. 
For instance, MERCs have been associated with some neurodegenerative disorders, including 
Alzheimer disease (AD), Parkinson’s disease (PD) and amyotrophic lateral sclerosis with associated 
frontotemporal dementia (ALS/FTD) (Paillusson et al., 2016). It is known that all the cellular 
functions regulated by MERCs are impaired in all these neurodegenerative diseases, clearly 
suggesting the involvement of MERCs in the progression of these diseases. 
In sections of brains obtained from human AD patients, an up-regulation of proteins associated 
with MAMs was observed (Hedskog et al., 2013). In addition, the accumulation of amyloid b-
peptide, characteristic from AD disease, as well as, the overexpression of presenilin 2, enhances 
the number of MERCs, and contributes to increased Ca2+ transfer between ER and mitochondria 
(Hedskog et al., 2013; Zampese et al., 2011).  
Parkinson’s disease is another disease where MERCs dysfunction seems to be present. The familial 
PD is characterized by mutation in the Parkin and PTEN induced putative kinase 1 (PINK1) genes 
(Deas et al., 2011; Kitada et al., 1998; Yu et al., 2011). It has been shown that Parkin-mediated 
mitophagy, and the recruitment of the autophagy machinery occurs in MERCs (Gómez-Suaga et 
al., 2018; Yang and Yang, 2013). Also, Gelmetti et al. showed that after mitochondrial 
depolarization, PINK1 and Parkin are re-located to MERCs (Gelmetti et al., 2017; Gómez-Suaga 
et al., 2018). However, some controversy exists regarding the modulation of these contact sites 
in a PD model. Some studies have reported that Parkin overexpression increases the MERCs and 
their functions (Calì et al., 2013). Contrary to the findings, Gautier et al. showed in PARK2 
knockout mice and in PD patients that MERCs were enhanced (Gautier et al., 2016). 
Furthermore, a-synuclein, a protein strongly linked to PD, was shown to be present in MERCs 
(Guardia-Laguarta et al., 2014). Indeed, a recent study reported that overexpression of wild-type 
a-synuclein increases mitochondrial Ca2+ uptake, and these findings were corroborated by an 




In ALS and FTD, accumulation of tar DNA-binding proteins-43 (TDP-43) is shown to be responsible 
for the pathology, and mutations in this gene cause also familial ALS and FTD (Paillusson et al., 
2016). TDP-43 overexpression reduces MERCs with consequent disruption in Ca2+ exchange (Stoica 
et al., 2014). This decrease of MERCs has shown to be caused by a disruption of VAPB-PTPIP51 
tethers (Stoica et al., 2014). Besides, Sigma 1 receptor, shown to also be  responsible for some 
familial forms of ALS/FTD , has been associated as well with reduction on MERCs following its loss 
(Bernard-Marissal et al., 2015).  
In different cancer types alterations in MERCs were also observed, highlighting the close 
relationship between processes which are altered during carcinogenesis and MERCs. Notably,  
several oncogenes and tumor suppressors have been found in MERCs (Sassano et al., 2017). For 
instance, PACS2 seems to be highly mutated  in sporadic colorectal cancer, thus supporting its role 
as a potential tumor suppressor (Raturi and Simmen, 2013). Also, it seems that the ability of cancer 
cells to adapt to intracellular stress can be modulated by signaling pathways present at MERCs 
(Sassano et al., 2017).  
Metabolic disorders have been also associated with MERCs disruption (López-Crisosto et al., 2015). 
For instance, in obese mice  an increase of MERCS accompanied with an excessive mitochondrial 
Ca2+ that resulted in mitochondrial impairment was observed (Arruda et al., 2014). Additionally, 
PACS2 or IP3R down-regulation in obese mice was reported to ameliorate cellular stress and glucose 
metabolism (Arruda et al., 2014). Moreover, the role of MERCs on hepatic insulin signaling and 
nutrient sensing has been characterized (Theurey and Rieusset, 2017). In the liver, overexpression 
of MERCs proteins enhances insulin signaling, revealing the crucial importance of MAM integrity 
for insulin signaling (Tubbs et al., 2014). In addition, hypertrophic cardiomyocytes showed insulin 
signaling disruption due to alterations in mitochondrial Ca2+ levels (Gutiérrez et al., 2014).  
 
 
1.3.5. Experimental approaches to investigate MERCs  
In order to elucidate the structural and functional role of MERCs, several approaches have been 
employed in this field. One of the first methods being used is transmission electron microscopy 
(TEM), which is a direct and preeminent approach since it offers the required high resolution to 
quantify the distance between both membranes, the number and the length of MERCs interface 
(Csordás et al., 2006). Therefore, TEM is considered the “gold standard” method to analyze the 
contact sites architecture. Besides, it is also possible to couple this technique with tomography, 
which provides a 3D nature of organelle contacts. However, these techniques are not widely 




to evaluate the MERCs. Another strategy that can be used is the proximity ligation assay (PLA) 
between two contact sites elements present on opposing membranes. This can be useful to analyze 
alterations in contact sites due to some cellular perturbations. For instance, protein complexes 
which have been associated with the tethering of ER and mitochondria, such as IP3R-VDAC1 or 
VAPB-PTPIP51, can be used for this technique (Stoica et al., 2014). However, there are some 
limitations with PLA, such as the requirement of the localization of PLA partners at the contact sites 
and requires the proper controls (Scorrano et al., 2019). 
A third strategy widely used in organelle research is the epifluorescence and confocal microscopy 
to evaluate the colocalization of cells expressing fluorescent proteins selectively targeted to the 
two organelles of interest, or by using markers  for the subcellular structures of interest which have 
been immunostained (Scorrano et al., 2019). This approach has advantages since it allows for live 
cell imaging, and it is a fast and amenable technique. On the other hand, there are limitations 
regarding the microscope resolution, which is approximately 250 nm in xy plane, because the 
distance between most of the contact sites are far smaller. Second, the chemical fixation for 
immunofluorescence can introduce some artifacts in the analysis of contact site  interactions 
(Scorrano et al., 2019). Nowadays, more focus is devoted in the field to developing strategies to 
overcome these limitations, such as fluorescence resonance energy transfer (FRET) and the split 
fluorescence reporters (Cieri et al., 2018; Scorrano et al., 2019). The FRET-based reporters allow to 
analyze the proximities between organelles, such as mitochondria and ER, and is based in the 
transfer of energy between fluorophores: a donor (for example cyan fluorescent protein) and an 
acceptor (yellow fluorescent protein for example) (Csordás et al., 2010). This technique is useful to 
investigate the contact sites dynamics and it is very sensitive to the distance between membranes. 
However, it is important to mention that this is a challenging approach and requires a special 
microscopy set up (Scorrano et al., 2019). On the other hand, split fluorescence probes, which  
includes split Venus or green fluorescence protein (GFP), are two non-fluorescent fragments 
targeted to the partner organelles, and only when these two portions encounter each other that 
they bind, and a fluorescent signal is emitted (Pinaud and Dahan, 2011). This experimental 
approach is advantageous since it is possible to discover new contact sites with this technique. It 
can also be used to perform rescue experiments by using synthetic tethers  (Scorrano et al., 2019).  
In addition to microscopy, the organelle contact sites in particular the MERCs can be explored in 
the context of biochemical approaches. The MAMs fraction was, for the first time, isolated by the 
group of J. Vance in the 1990s. This  cellular fraction was enriched in ER and OMM membranes 
(Vance, 1990). This biochemical procedure can be applied for different mammalian tissues and cells, 




separated from pure mitochondria by gradient centrifugation. With this approach, it is possible to 
study the composition of MERCs, by analyzing proteins, which are present in the contact sites, as 
well as to evaluate how the proteins change in response to the cellular environment. In addition, 
the purified fraction can be subsequently used for mass-spectrometry to reveal other unknown 
components. Like the other methods, some disadvantages are present, such as contamination from 
other organelles. 
Given the essential role of MERCs in several cellular functions, it is also important to take into 
account functional studies in order to confirm morphological alterations in MERCs, together with 
its impact on cellular functions. For this purpose, several functional studies in both cell lines and 
isolated tissues take advantage of the role of MERCs in Ca2+ transfer and lipid exchange between 
organelles (De Brito and Scorrano, 2008; Filadi et al., 2015; Galmes et al., 2016; Naon et al., 2016; 
Stoica et al., 2014; De Vos et al., 2012). The evaluation of Ca2+ exchange is one of the most applied 
approaches, and it is used in living cells, since it is possible to increase the mitochondrial Ca2+ uptake 
by stimulating its release from ER in response to some exogenous agents that act on IP3R (for 
example, histamine). As a result, strategies such as using recombinant targeted protein 
sensors (Bravo et al., 2011; Rizzuto et al., 1992) or fluorescent chemical indicators (Matsuzaki et al., 
2013) have been employed. Regarding the lipid transfer between organelles, it is possible to 
quantify the conversion of PS-to-PE or the PS content in mitochondria (Vance, 1990). This is possible 
by using radioisotopes to label phospholipids in order to identify and quantify them by thin layer 


















1.4. Aims of this study 
Over the last decade, the research based on organelle contact sites and inter-organelle 
communication has grown, and new insights into its roles in cell physiology have been discovered, 
namely molecular components and functions of contact sites. In the case of MERCs, they are 
implicated in several cellular functions (e.g. Ca2+ buffering, lipid trafficking, mitochondrial 
morphology), and their disruption has been associated with pathological conditions. Despite the 
fact that MERCs are one of the most studied contact sites, there are still outstanding questions, in 
particular if and how MERCs respond to cellular signaling, and the basic understanding of their 
regulation, primarily, their association and dissociation. Additionally, given the molecular 
complexity of the mitochondria-ER interface, it is plausible to hypothesize its implication in key 
signaling pathways, including the ones, which are activated following mitochondrial stress. Taken 
together, the goal of this study was to understand if and how mitochondrial malfunction affects the 
communication between mitochondria and ER. To this end, the specific aims of this study were to: 
• determine the response of MERCs to acute and chronic mitochondrial stress in 
mammalian cells. 
• identify signaling pathways linking mitochondrial malfunction to the formation and 











2. MATERIAL AND METHODS 
2.1. Material 
2.1.1. Reagents 
Several chemicals and reagents were used in this study. The respective lists of reagents and their 
suppliers are provided in the table below. 
 





2-Mercapthoethanol Carl Roth 4227.3 
A769662 Cayman chemical 11900 
Absolute ethanol BD Bioscience 354052 
Acrylamide solution 40% AppliChem A0385 
Agar 100 Premix kit-hard Agar Scientific AGR1140 
Agarose Carl Roth 3810.3 
Ammonium Persulfate (APS) AMRESCO 0486 
Antimycin Sigma Aldrich A8674 
Bovine serum albumin (BSA) Sigma Aldrich A7906 
Bromophenol blue Carl Roth T116.1 
Cacodylic acid sodium salt trihydrate Carl Roth 5169.1 
CCCP Fluka 857815 
Cold fish gelatin Sigma Aldrich G7765 
Coomassie Brilliant Blue G Carl Roth 9598.2 
D (+)-Glucose Carl Roth 275227941 
DAPI Carl Roth C6335.1 
DMEM High glucose Gibco 41965-062 
DMEM high glucose + pyruvate Gibco 41966-029 
DMSO Sigma Aldrich D8418 
DTT AppliChem A2948 
Dulbecco´s Modified Eagle´s Medium (DMEM) 
Base 
Sigma Aldrich D5030-1L 
EDTA Carl Roth 8043.2 
Ethanol 70% VWR 84858.440 
FCCP Sigma Aldrich C2920 
Fetal Bovine Serum Heat Inactivated Gibco 10500-064 
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Fugene R6 Transfection Reagent Promega E2691 
GlutaMax-1 (100X) Gibco 35050-061 
Glycerol Carl Roth 7530.1 
Glycine VWR 0167 
Goat Serum Life Technologies 10000C 
H2O Nuclease-free VWR E476 
HaltTM Protease & Phosphatase single use Inhibitor 
Cocktail 
Thermo Scientific 78442 
HCl Sigma Aldrich H1758 
HEPES Carl Roth HN77.2 
K2HPO4 Carl Roth P749.2 
KCl Volu-Sol 83608.26 
KH2PO4 Carl Roth 3904.1 
Methanol VWR 20903.368 
MgCl2 VWR 8.14733.0100 
MgSO4 – 7H2O Sigma Aldrich 63138 
Mowiol 4-88 AppliChem A9011 
N-dodecylmaltoside Carl Roth CN26.2 
NaCl AppliChem A1430,0010 
NaH2PO4.H2O Carl Roth K300.1 
NaHCO3 Carl Roth P029.3 
NaN3 Sigma Aldrich 52002-1006 
NH4Cl Carl Roth K298.1 
Nonidet®P-40 Substitute AMRESCO E109-50ML 
Oligomycin Sigma Aldrich O4876 
Osmium tetroxide (OsO4) Electron Microscopy Sciences 19134 
PageRuler Plus Prestained Protein Ladder Thermo Scientific 26619 
Paraformaldehyde (PFA) AppliChem A3813 
PMSF Sigma P7626 
Polybrene Sigma 28728-55-4 
Potassium ferrocyanide Sigma P9387 
Puromycin 100mg Fisher Scientific BP2956-100 
SDS Sigma Aldrich L4509-500G 
Skim Milk Powder Fluka 70166 
TEMED Sigma Aldrich T7024 
Tris Base Sigma Aldrich T1503 
Tris-HCl Carl Roth 9090.2 
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Triton X-100 AMRESCO 0694 
Trypan Blue 0.4% Life Technologies T10282 
Tween 20 AMRESCO 0777-1L 
Uranyl acetate (UA) Agar Scientific AGR1260A 
 
Uridine Sigma Aldrich U3003 
 
 
2.1.2. Kits and disposables 
The kits and disposables used throughout this thesis, with their corresponding suppliers and catalog 
numbers, can be found in the table below (Table 2). 
 
Table 2 | List of kits and disposables used in the study. 
 
Product Supplier Catalog number 
Amersham Hybond PO45 PVDF GE Healthcare 10600023 
Centrifuge tubes 15 mL Corning CentriStar Corning 430791 
Centrifuge tubes 50 mL Corning CentriStar Corning 430829 
CRYSTAL RNA Mini Kit New England Biolabs 31-010-404 
Cuvettes PMMA VWR-International 634-0678 
FACS Tubes Polystyrene Round-Bottom 5 mL Corning 352052 
High Performance chemiluminiscence film GE Healthcare 28906837 
Lenti X concentrator Clontech 631231 
LuminataTM Classico Western HRP Substrate Millipore WBLUC0500 
Luna® Universal qPCR Master Mix New England BioLabs M3003 
Medical X-Ray Film Foma ----- 
Microscope slides Carl Roth 2111 
MitoSOXTM Red Life Technologies M36008 
PBS tablets Sigma Aldrich P44177-100TAB 
Penicillin/Streptomycin Gibco 15140-062 
Pierce BCA Protein Assay Kit Thermo Scientific 23225i 
Protein Assay Dye Reagent Concentrate Bio-Rad 500-0006 
Serological Pipette 10 mL StarLab E4860-1011 
Serological Pipette 25 mL StarLab E4860-2511 
Serological Pipette 5 mL StarLab E4860-0511 
Sodium Pyruvate Sigma S8636 
Test Tube Soda Glass VWR-International 212-003 
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Tips 10 µL TipOne StarLab S111-3210 
Tips 1000 µL TipOne StarLab S1111-6001 
Tips 20 µL TipOne StarLab S120-1810 
Tips 200 µL TipOne StarLab S1120-8800 
Triplet Express (1X) Gibco 12605-010 
Trypan Blue 0.4% Life Technologies T10282 
Tubes 0.5 mL molecular probes Life Technologies Q33856 
Tubes 1.5 mL StarLab E1415-1500 
Tubes 2 mL StarLab S1620-2700 
Western Blot Paper TH-Geyer 4-01-60-0041 
XFe 96 extracellular flux assay kit Seahorse BD Bioscience 102416-100 
 
 
2.1.3. Buffers and solutions 
All buffers and solutions used in this study are listed below in Table 3. Unless otherwise stated, all 
buffers and solutions were prepared in ddH2O and concentrated buffers were further diluted to 1X 
in ddH2O also.  
 





5% (w/v) Skimmed milk or BSA in TBST 
  Blocking buffer 
(Immunocytochemistry) 
0.1% Cold fish gelatin, 0.1% Triton X-100, 3% BSA, 1% Goat serum and 
0.05% Tween-20 in PBS 
Cacodylate buffer 0.2M of Cacodylic acid sodium salt trihydrate in ddH2O, pH 7.4 
Ferrocyanide solution 1.5% (w/v) of ferrocyanide in ddH2O 
Freezing medium 
(Cell culture) 
10% (v/v) DMSO, 20% (v/v) FBS in DMEM high glucose 
Mowiol 6.4mM Mowiol 4-88, 5.4M Glycerol, 0.1M Tris pH 8.5 
MS homogenization buffer 210 Mm mannitol, 70 mM sucrose, 5 mM Tris-HCl, 1 mM EDTA, pH 
7.5 
NaN3 10% NaN3 
Osmium tetroxide (OsO4) 4% (w/v) of OsO4 in 0.1M cacodylate buffer 
PBS 5 PBS tablets in 1L ddH2O 
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Resolving gel 12% 
 
0.375M Tris, pH 8.8, 0.1%SDS, 12% Polyacrylamide, 0.1% APS, 0.04% 
TEMED 
Ringer’s buffer 
55 mM NaCl, 4.5 mM KCl, 10 mM glucose, 5 mM HEPES, 2.75 mM 
MgCl2, 0.5 mM CaCl2, pH 7.4 37 °C 
RSB hypo buffer 10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl, pH 7.5 
Running buffer 1x 5mM Tris, 192mM glycine, 0.1% SDS 
SDS loading buffer 
62.5mM Tris, pH 6.8, 50 % (v/v) Glycerol, 12 % (w/v) SDS, 0.06 % (w/v) 
Bromophenol blue. Add 5% 2-Mercaptoetanol freshly prior to use 
Stacking gel 4% 
 
62.5mM Tris pH 6.8, 0.1% SDS, 4% Polyacrylamide, 0.1% APS, 0.05% 
APS % TEMED 
Sucrose density gradient 1.0 M sucrose or 1.5 M sucrose, 10 mM Tris-HCl, 1 mM EDTA, pH 7.5 
TBST 10X 200mM Tris, 1.5M NaCl, 1% Tween 20, pH 7.4 
TE buffer 10mM Tris-HCl, 0.2mM EDTA pH 7.5 
Transfer buffer 10X 250mM Tris, 1.92M Glycine. 1X dilution includes 20% (v/v) Methanol 
Uranyl Acetate (UA) 4% (w/v) of UA in ddH2O 
Whole cell extraction buffer 





Different primary and secondary antibodies were used for immunoblotting (IB) and 
immunocytochemistry (ICC) experiments in this thesis. These antibodies are listed below.  
 
Table 4 | Primary antibodies for immunoblotting and immunocytochemistry. 
 
Antibody Supplier Catalog number Application Dilution 
ACC Cell signaling 3676 IB 1:1000 
ACC pSer79 Cell signaling 3661 IB 1:1000 
AMPKα1 Cell Signaling 2795 IB 1:1000 
AMPKα1 Novus Biologicals NBP2-22127 IB 1:1000 
DRP1 BD Biosciences BD-611113 IB/ICC 1:1000/1:50 
GAPDH Sigma Aldrich G9545 IB 1:10000 
HPRT Abcam ab10479 IB 1:4000 
MFF Proteintech 17090-1-AP IB 1:1000 
MFN2 abcam ab124773 IB 1:1000 
S6 Cell signaling 2217 IB 1:2000 
S6 pSer235/236 Cell signaling 4858S IB 1:2000 
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TOM20 Proteintech 11802-1-AP IB/ICC 1:1000/1:200 
UQCRC1 Abcam ab110252 IB 1:2000 
VAPB biomol A302-894A-M IB 1:1000 
VDAC1 abcam ab14734 IB 1:1000 
 
Table 5 | Secondary antibodies for immunoblotting and immunocytochemistry. 
 
Antibody Supplier Code Applications 
Goat anti-mouse Alexa 568 Life Technologies A-11031 ICC 
Goat anti-mouse IgG Dianova 115-035-146 IB 
Goat anti-rabbit Alexa 488 Life Technologies A-11008 ICC 
Goat anti-rabbit IgG Dianova 115-035-144 IB 
 
 
2.1.5. Cell culture materials  
The following materials and devices were used specifically for cell culture experiments carried out 
in this study. 
 
Table 6 | Cell culture materials and devices. 
 
Product Supplier Catalog number 
100 x 20 mm TC dish Starlab CC7682-3394 
12-well TC plate Starlab CC7682-7512 
150 x 20 mm TC dish Starlab CC7682-3617 
6-well TC plate Starlab CC7682-7506 
60 x 20 mm TC dish  Starlab  CC7682-3354 
96-well TC plate Starlab CC7682-7596 
Cell scraper StarLab CC7600-0202 
Countess cell counting chamber slides Invitrogen C10283 
Coverslips Marienfeld 017580 
Cryogenic vial 2 mL Fisher Brand 1050026 
Filter syringe 0.22 Ø Rotilabo CME Carl Roth SE2M35I07 








The transfections in this study were performed with pcDNA and shRNA listed below (Table 9). 
 
Table 7 | Plasmids and shRNA used in this study. 
 
Plasmid Supplier Catalog number 
4mtD3cpv Kind gift from Prof. Dr. Ivan Bogeski 
EGFP-TMsac1 Kind gift from Dr. Ira Milosevic 




pLenti.PGK.blast-Flag-MFF-S155,172D Addgene 74442 
pLenti.PGK.blast-Flag-MFF-WT Addgene 74379 
pLKO.1-blast-scrambled Addgene 26701 
PLP1, PLP2, PLP-VSVG Kind gift from Prof. Dr. Katschinski 
Scrambled negative control Integrated DNA Technologies 51-01-19-09 
shRNA-UQCRC1 GE Dharmacon TRCN0000046483 
shRNA-UQCRC1 GE Dharmacon TRCN0000046484 
shRNA-UQCRC1 GE Dharmacon TRCN0000046485 
shRNA-UQCRC1 GE Dharmacon TRCN0000046486 




All the equipment used in this study is listed in Table 10 below. 
 
Table 8 | List of equipment. 
 
Equipment Manufacturer 
Ace Block Digital Dry Bath Labnet 
Amaxa 4D-Nucleofector Lonza 
Bio-Rad Power Pack HC Mini-Protean Tetra System Bio-Rad 
CAWOMAT 2000 CAWO 
Cell Observer High Speed microscope Zeiss 
Centrifuge 5415R Eppendorf 
Centrifuge 5810R Eppendorf 
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Centrifuge Allegra X-15R Beckman Coulter 
Countess C10281 Invitrogen 
FACS CantoTMII BD Biosciences 
Gene Quant 1300 GE Healthcare 
Hood Herasafe Thermo Scientific 
Incubator Heracell 150i Thermo Scientific 
JEM 1011 transmission electron microscope  JEOL 
Microscope Zeiss Axio Vert A1 Zeiss 
Nanodrop 2000C Peqlab 
Potter S homogenizer Sartorius 
Quant Studio 6 Flex Life Technologies 
Scanner Epson Perfection V850 Pro Epson 
SE600 Ruby system GE Healthcare 
Seahorse XF96 extracellular Flux Analyzer Agilent 
SYNERGYM1 microplate reader BioTek 
Vortex RS-VA10 Phoenix Instrument 




Several software were used to analyze most of the data obtained from experiments carried out in 
this study. The table below lists these software packages and their manufacturers 
 
Table 9 | List of software. 
 
Software Manufacturer City/State Country 
Adobe Illustrator CS6 Adobe Systems Inc. San Jose, CA USA 
FACS DIVATM software BD Biosciences Heidelberg Germany 
FlowJo FlowJo LLC Ashland, OR USA 
GraphPad Prism 6 & 7 GraphPad Software Inc. La Jolla, CA USA 
ImageJ NIH Bethesda, MD USA 
Imaris Bitplane Zurich Switzerland 
Mendeley Mendeley Ltd. London UK 
Microsoft Office Microsoft Corporation Redmond, WA USA 






2.2.1. Cell Culture   
2.2.1.1. Cell lines and culture growth conditions  
In the present work, HeLa cells and mouse embryonic fibroblasts (MEFs) were used.  
The HeLa cell line was purchased from ATCC (LGC Standards, Middlesex, UK). AMPK MEFs, 
AMPKα1-/-α2-/- and the corresponding wild-type, were a kind gift of Dr. Benoit Viollet (Institut 
Cochin, Paris, France). MFF-/- MEFs and the corresponding wild-type, were a kind gift of Dr. David 
Chan (Caltech, California, USA). All the cell lines used were stored frozen in liquid nitrogen vapor 
phase and expanded according to manufacturer’s instructions.  
HeLa RC-kd and scrambled control cells were grown in sterile Dulbecco's Modified Eagle Medium 
high glucose medium (DMEM) with 1mM pyruvate supplemented with 10% fetal bovine serum 
(FBS), 1% Penicillin/Streptomycin (P/S) and 200 µM uridine at 37°C and 5% CO2. All MEFs used 
were cultured in sterile DMEM supplemented with 10% FBS and 1% P/S at 37°C and 5% CO2. 
Cells were seeded at least 24 hours before experiments and harvested at 70-80 % confluence 
for all experiments. For routine subculturing, cells were first rinsed with sterile 1x Phosphate 
Buffered Saline (1x PBS; 0.137 M NaCl, 2.7 mM KCl, 1.4 mM KH2PO4, 0.01 M Na2HPO4) and then 
incubated with 1 volume of trypsin-EDTA for 5 min at 37°C. Trypsin activity was inhibited by the 
addition of 1 volume of complete growth medium and the final volume centrifuged at 1000xg 
for 3 min at room temperature. An appropriate aliquot of the cell suspension was added to new 
culture flasks. This procedure was repeated when cultures reached 80-90% confluence. 
 
 
2.2.1.2. Generation of stable knock down and overexpression cell lines 
Lentiviral stable knockdown generation was done by growing HEK293T packaging cells in DMEM 
high glucose (Gibco) supplemented with 10% FBS and after 24h cells were transfected with viral 
components (an optimized mix of packaging plasmids PLP1, PLP2 and PLP/VSVG) and shRNA 
against target genes (or scrambled control) using Lipofectamine 2000, grown and concentrated 
using Lenti-X Concentrator (Clontech) according to the manufacturer’s instructions. The shRNA 
constructs were purchased from Open Biosystems (Dharmacon). HeLa cells were then seeded 
at 12000 cells/cm2 and grown overnight to 70-80% confluence. These cells were transduced 
with the lentiviral particles using Polybrene (8µg/ml) and puromycin was used as selection 
agent. For stable knockdown, efficiency was confirmed by Western blot. The best knockdown 
was selected for subsequent experiments. For stable MFF overexpression, lentiviral suspensions 
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were obtained as described before using packaging and envelope viral vectors with MFF 
constructs (purchased from Addgene, Cambridge, USA). AMPK DKO MEFs were then seeded at 
1x105 cells and grown overnight to 70-80% confluence. These cells were transduced with the 
lentiviral particles using Polybrene (8µg/ml) and puromycin resistant cells were selected. 
 
 
2.2.1.3. Transfection of HeLa RC-kd and mouse embryonic fibroblasts 
HeLa RC-kd cells were seeded 24h before transfection in 12-well-plates with coverslips coated 
with poly-lysine for microscopy. Afterwards, cells were transfected using FuGENE HD 
Transfection Reagent (1 µg of DNA: 3 µL of FuGENE). The transfecting mix was prepared by 
adding 3 µL of FuGENE directly into 50 µL of Opti-MEM medium, mixed and incubated for 5 
minutes at room temperature. In the meanwhile, in another microcentrifuge tube, 50 µL of Opti-
MEM medium and 1 µg of respective DNA was prepared and mixed. Finally, DNA dilution was 
added to the FuGENE dilution, mixed and incubated for 20 minutes at room temperature. 
Following incubation, the transfection mix was added to the wells dropwise and gently mixed. 6 
hours post-transfection, the medium was changed with fresh medium and cells were kept for 
24 hours at 37°C and 5% CO2.  
Mouse embryonic fibroblasts were transfected with respective plasmids using electroporation, 
following manufacturer’s instructions. Briefly, after collecting cells as described before, the cell 
pellet was resuspended in warm growth medium and 10 µL of the suspension was applied to an 
improved Neubauer cell counting chamber. The cell density was determined by the formula: 
! × 10% where N is the average cell number in the four corner squares. Following cell density 
determinations, 5 x 105 cells were pelleted and the excess medium aspirated. 20 µL of Amaxa 
transfection working reagent (made of 263µL reagent A and 62.5µL reagent B) was added to the 
cell pellet. Plasmids (1 µg) were added and the cell pellet was resuspended by gently pipetting 
up and down. The cell suspension was transferred to labeled electroporation small cuvettes and 
electroporated with the appropriate program for dermal MEFs using the Amaxa 4D 
Nucleofector. The electroporated cells were then incubated at room temperature for 10 
minutes, resuspended in warm growth medium and seeded (3 x 104 cells/well) into appropriate 
12-well plates for microscopy. The transfected cells were cultured in normal growth conditions 
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2.2.2. Material harvesting 
2.2.2.1. Cells harvesting for total protein 
In order to prepare the whole cell lysates, adherent cells were harvested by aspirating the 
growth medium and washed once in PBS 1x. Then, cells were scraped on ice with ice cold PBS 
1x and the cell suspension was collected and pelleted at 2500 rpm, 4 °C for 5 minutes. The cell 
pellet was used for the required technique or frozen in liquid nitrogen and stored at -80 °C for 
later use. For specific techniques, such as flow cytometry, cryopreservation and transfection of 
MEFs (described later), the whole cell extract was prepared differentially using trypsinization. 
For this purpose, the growth medium was aspirated, and adherent cells were washed with warm 
PBS 1x and. Then, TrypLE Express enzyme was added for cell detaching, and cells were incubated 
during 5 minutes at 37 °C. The trypsin activity was inhibited by adding twice the volume of 
growth medium and subsequently, the cell suspension was collected and subjected to 
centrifugation at 1,500rpm, 4 °C for 5 minutes. the cell pellet used for further experiments and 
the supernatant was discarded. 
 
 
2.2.2.2. Subcellular fractionation 
The crude mitochondria and pure mitochondria were prepared as described previously with 
some modifications (Clayton and Shadel, 2015; Clayton et al., 2014). The preparation of further 
subcellular fractions (microsomes and cytosol) was adapted from Wieckowski et al. (Wieckowski 
et al., 2009). Briefly, AMPK MEFs grown on 15-cm dishes were resuspended in RSB hypo buffer 
(10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris-HCl, pH 7.5) and homogenized using Potter-Elvehjem 
homogenizer with a Teflon pestle. Following homogenization, cells were subjected to 
differential centrifugation in order to obtain nuclear/whole cell, crude mitochondrial, and 
microsomal fractions. Supernatants were collected in order to obtain cytosolic/microsomal 
fractions. The crude mitochondrial fraction in MS homogenization buffer (210 Mm mannitol, 70 
mM sucrose, 5 mM Tris-HCl, 1 mM EDTA, pH 7.5) was subjected to sucrose density gradient 
centrifugation (1.0 M sucrose or 1.5 M sucrose, 10 mM Tris-HCl, 1 mM EDTA, pH 7.5) to obtain 
pure mitochondria. Cytoplasmic fractions were ultracentrifuged at 100,000 ´g for 1h at 4 ºC to 
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2.2.3. Biochemical procedures 
2.2.3.1. Preparation of whole cell lysates from adherent cells 
For the preparation of whole cell lysates, cell pellets from previously harvested adherent cells 
were resuspended on ice in 50–150 µL of lysis buffer (1.5% N-dodecyl β-D-maltoside in PBS 1x 
supplemented protease and phosphatase inhibitor), depending on pellet size. Afterwards, the 
cell suspension was lysed by rotation at 4 °C for 30 minutes and centrifuged during 20 minutes 
at 16,000 rpm in order to obtain the cell homogenate. The supernatant (whole cell lysate) was 
collected and the protein concentration was measured by the Bradford Assay. The lysates were 




2.2.3.2. Protein concentration determination using Bradford assay 
For the determination of protein concentrations, Protein Assay Dye Reagent Concentrate (Bio-
Rad) was used accordingly manufacturer’s protocol. For this purpose, protein concentration of 
cell lysates and standards using bovine serum albumin (BSA) was determined by mixing, 800 µL 
of ddH2O, 1 µL of sample or standard and 200 µL of protein assay dye reagent concentrate in a 
glass tube and vortexed briefly. Afterwards, the tubes were incubated during 5 minutes at room 
temperature in the dark and transferred into plastic cuvettes. The absorbance at 595 nm was 
measured using a GeneQuant 1300 spectrophotometer. The protein concentration of the cell 
lysates was calculated based on the standard calibration curve. 
 
 
2.2.3.3. SDS-PAGE and Immunoblotting  
After protein quantification, equal amount of protein from cell lysates was mixed with 
homemade 6x SDS loading buffer and with the appropriate volume of ddH2O to load the same 
amount of protein in each well and boiled for 5 minutes at 95ºC. These steps allow for protein 
denaturation and therefore loss of quaternary, tertiary and secondary protein structure. 
Moreover, proteins obtained a uniform negative charge, which masks the intrinsic charges on 
the amino acids side-chain. Consequently, after this point, proteins can be separated solely as a 
function of their molecular size by SDS-PAGE (Gallagher and Ii, 2006). To accomplish that, 
samples (10 to 25 μg of protein) were loaded in a discontinuous vertical polyacrylamide gel 
electrophoresis system. Polyacrylamide gels were formed by copolymerization between 
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acrylamide and bis-acrylaminde through a vinyl addition polymerization reaction initiated with 
the addition of ammonium persulfate (APS) and catalysed by tetramethylethylenediamine 
(TEMED). To run the SDS-PAGE, the Mini Protean Tetra System (Bio-Rad) was used filled with 1x 
running buffer and connected to a PowerPac Basic Power Supply (Bio-Rad) outputting an initial 
constant amperage of 20 mA per gel and switched to constant 30-40 mA when samples were in 
the resolving gel. Separation was carried out at room temperature and until the front of the run 
reached the bottom end of the gel. Note that in every gel, a molecular weight standard 
(PageRuler plus Prestained ladder) was included to allow molecular weight estimation.  
Once protein separation was complete, Western blot was carried according to protocols 
described by (Gallagher and Ii, 2006). Briefly, polyvinylidene fluoride (PVDF) membranes were 
pre-activated (1 minute in methanol, washed 1 minute with ddH2O followed by 15min in 
transfer buffer 1x). For the protein transfer, gels were placed in a 'transfer sandwich' (filter 
paper-gel-membrane-filter paper), cushioned by wet sponges and pressed together by a support 
grid/cassette. The supported gel sandwich was then placed in the transfer apparatus in a tank 
filled with 1X transfer buffer while ensuring the correct orientation (bottom half towards 
cathode). A cold ice pack was also placed in the tank to avoid excessive heating of the transfer 
buffer. Protein transfer was performed at a constant voltage (100mV) during 90 min with a 
PowerPacTM Basic Power Supply (Bio-Rad). Once protein transfer was complete, the membranes 
were blocked in blocking buffer with mild shaking for 1 hour at RT, to avoid non-specific binding. 
The membranes were then washed three times in 1X TBST for 5 minutes and labeled with 
primary antibodies (diluted in blocking buffer) by overnight incubation at 4 °C. On the next day, 
membranes were washed three times for 10 min each with 1X TBS-T and incubated with 
appropriate HRP-conjugated secondary antibodies diluted in blocking buffer at RT for 1 hour and 
washed three more times in 1X TBST for 10 minutes. Signals representing proteins by 
chemiluminescence were detected by draining excess 1X TBST on membranes, incubating 
membranes in Luminata Western HRP substrate for 3 minutes and developing signals on medical 
X-ray films using the AGFA Curix 60 processor. The films were scanned with the Epson Perfection 
V850 Pro Scanner. Band density quantification was determined using ImageJ after subtraction 




For immunoprecipitation, cells were used at approximately 80% of confluence. For collection 
and lysis, cells were harvested using cell scraper, lysis and protein extraction was performed as 
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described before (see 3.2.3.1.). After protein quantification by Bradford assay, 500 µg of protein 
in 500 µl of WCE buffer was prepared. Afterwards, protein G agarose (30 µl per IP) was 
equilibrated with 500 µl PBS1x prior to adding it to lysate and centrifugated at 2000xg for 2 min. 
After centrifugation, supernatant was removed and 500 µl of the prepared cell lysate (containing 
500 µg of protein) was added. The antibodies (5 µl of antibody per IP) were added to the 
previous solution and incubated at 4°C overnight with gentle rotation.  
On the next day, centrifugation at 2000xg for 2 minutes was performed and the supernatant 
discarded. In the next step, 500 µl of WCE was added and incubated during 5 minutes at 4°C 
with rotation, followed by centrifugation at 2000xg for 2 minutes. This was repeated for at least 
4 times and in the last step most of the supernatant was removed and approximately 40 µl of 
SDS loading dye was added to the beads. The samples were boiled for 5 minutes at 95°C and 
centrifuged at maximum speed (16000xg) for 1 minute and 10 µl of the supernatant was 
analyzed by western blotting. 
 
 
2.2.5. Evaluation of oxygen consumption  
Respirometry of cultured cells in this study was evaluated using the Seahorse XF96 Extracellular 
Flux Analyzer (Seahorse Bioscience). The XFe 96 extracellular flux assay kit was used following 
manufacturer’s protocols. Cells were seeded in the XF96 cell culture plate in 200 µL normal 
growth medium per well and cultured overnight. In the same day, it was prepared the the XFe 
96 sensor cartridge plate by adding 200 µL of XF calibrant to it and incubated in a non-CO2 
incubator at 37 °C overnight. Next day, XF medium was prepared by supplementing with 25mM 
glucose and pH adjusted to 7.4 and the previously cultured cells were washed with PBS 1x and 
the medium was replaced with 180 µL of warm XF medium and incubated at 37°C for 1 hour 
without CO2. During this incubation time, the sensor cartridge was loaded in the indicated ports 
with different compounds which were prepared in warm XF medium. The compounds were 
10µM Oligomycin (20µL per well loaded in Port A), 20µM FCCP (22µL per well loaded in Port B) 
and 10µM each of Rotenone and Antimycin (25µL per well loaded in Port C). Afterwards, the 
sensor cartridge plate was loaded and calibrated in the XF96 extracellular Flux Analyzer. Once 
the calibration was completed, the XF96 cell culture plate was loaded into the XF96 extracellular 
Flux Analyzer at 37 °C and a MitoStress Test was run using the XFe analyzer software. All results 
were averages of at least technical triplicates of three biological replicates. 
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2.2.6. Flow cytometry 
2.2.6.1. Mitochondrial membrane potential  
Mitochondrial membrane potential was determined by flow cytometry using JC1 dye (Molecular 
Probes) according to manufacturer’s recommendation. Briefly, 5mM of JC1 stock was prepared 
by resuspending in DMSO. The JC1 working solution (20 µM) was prepared in warm DMEM 
medium. Previously, cultured cells were washed with warm PBS 1x, stained by adding JC1 
working solution to cells, and incubating at 37°C for 20 minutes. Afterwards, the excess of dye 
was washed off the cells twice with warm PBS 1x and cells were harvested by trypsinization as 
described before. Then, cells were centrifuged at 1500 rpm for 5 minutes and resuspended in 
1000 µL of cold PBS 1x. Cell suspension was transferred to FACS tubes along with unstained cells, 
stained test samples and positive controls (treated with 10 µM of FCCP) and mitochondrial 




2.2.6.2. Measurement of mitochondrial superoxide levels 
The MitoSOX Red mitochondrial superoxide indicator (Molecular Probes) was used in order to 
measure mitochondrial superoxide levels by flow cytometry according to manufacturer’s 
protocol. For this purpose, 5 mM MitoSOX concentration stock was prepared by resuspending 
each 50µg dye vial in 13 µl DMSO. The MitoSOX working solution was prepared at the 
concentration of 5 µM with warm PBS 1x supplemented with 0.5 µM of glucose. The cultured 
cells were washed with PBS 1x and stained with MitoSOX working solution by incubating at 37 
°C for 15 minutes. Following staining, cells were washed with warm PBS 1x and harvested by 
trypsinization as described before. Afterwards, cells were washed twice with PBS 1x and 
centrifuged during 5 minutes at 1500 rpm. The cell pellet was resuspended in 500 µL of PBS 1x 
supplemented with 0.5 µM of glucose. Cell suspension was transferred to FACS tubes along with 
unstained cells, stained test samples and mitochondrial superoxide levels were determined by 
flow cytometry. As positive controls, cells were treated with 100 µM H2O2 or 100 µM Antimycin 
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2.2.7. Immunocytochemistry  
Cells seeded in 12-well-plates containing coverslips were washed with PBS 1x and fixed using 4% 
of PFA. After that, the PFA was removed and the coverslips were washed 3 times with PBS 1x. 
Cells were blocked and permeabilized with 500 µL of blocking solution during 1h at room 
temperature with mild shacking. Then, the coverslips were incubated with primary antibodies 
overnight at 4°C. The next day, the antibodies were removed, and the coverslips were washed 
thrice with PBS 1x for 10 minutes. After the wash, the coverslips were incubated with secondary 
antibodies (1:200) for an hour at R/T in the dark. When the incubation was completed, the 
antibody was removed, and the coverslips washed three times again with PBS for 10 minutes. 
The coverslips were mounted on slides using Mowiol, dried, sealed with nail polish and stored 
in the dark at 4°C until imaged.  
 
 
2.2.8. Confocal microscopy and image analysis  
HeLa RC-kd cells and MEFs were plated and transiently transfected as described before on 
coverslips in 12 well-plates at normal growth conditions and fixed after 24 hours. Images were 
obtained using a Zeiss LSM 800 Laser Scanning Microscope with Airyscan. Images were acquired 
with the same parameters throughout all experiments. All settings were saved and applied to 
subsequent imaging sessions for comparable groups. Post-acquisition image analyses were 
carried out with ZEN software (Zeiss) and ImageJ. 
 
 
2.2.9. Electron microscopy and image analysis 
Cells seeded on 24 mm round glass coverslips were fixed with 2.5% (vol/vol) glutaraldehyde in 
0.1 M sodium cacodylate during 1h at room temperature. After washing with 0.1M cacodylate 
buffer, cells were post-fixed with 1% of OsO4 solution and 1.5% of ferrocyanide in 0.1M of 
cacodylate during 1h at room temperature. The samples were then washed three times in 0.1M 
of cacodylate buffer followed by a further three times washes in Millipore water and then 
incubated in 1% aqueous uranyl acetate at 4 °C overnight. Then, cells were rinsed with Millipore 
water, dehydrated with ethanol and infiltrated in Epon using 1:1 (v/v) resin and anhydrous 
ethanol for 1h. Additionally, two steps of 100% resin during 1h were performed. After, the cells 
were incubated at 45 °C for one overnight followed by a second overnight at 60 °C. Thin sections 
Material and Methods 
 
 49 
were obtained and imaged using a JEM 1011 transmission electron microscope (JEOL) operated 
at 80 kV, equipped with a Gatan Orius 1200A camera using the Digital Micrograph software 
package. Two independent experiments were performed, and each sample was labeled with a 
numerical code. The electron microscopy images were collected blinded at 4000x or higher 
magnification and then imported into ImageJ (National Institutes of Health) for further analysis.  
Morphometric analysis was carried out at least in 100 images per condition with > 5 
mitochondria per image. The analysis of MERCs number, mitochondrial perimeter and length, 
were also carried out blind, using ImageJ software and setting 30 nm as the maximum distance 
from any segment of an ER tubule to a mitochondrion in order to be considered a contact site. 
In ImageJ software, the mitochondrial perimeter for each clearly defined mitochondrion was 
outlined by drawing a freehand line and measured. These values were then averaged to get the 
average mitochondrial perimeter for a given sample. To measure the length of the contact, it 
was drawn a freehand line from the beginning to the end of the mitochondrion-ER contact that 
was considered before. These values were then averaged to get the average length of contact 
sites for a given sample. 
 
 
2.2.10. Mitochondrial calcium measurement  
Mitochondrial Ca2+ was measured using 4mtD3cpv (mitochondrial cameleon). Cells seeded on 
25 mm round glass coverslips were transiently transfected with 1 µg of 4mtD3cpV using Fugene 
6 Transfection Reagent (Promega) according to the manufacturer’s instructions and as described 
before (see 2.2.1.3.). The experiments were performed 48 h after transfection. On the 
experimental day, cell-containing glass coverslip was inserted into the microscopy chamber and 
the growth medium replaced by Ringer’s buffer (55 mM NaCl, 4.5 mM KCl, 10 mM glucose, 5 
mM HEPES, 2.75 mM MgCl2, 0.5 mM CaCl2, pH 7.4 37 °C). The image acquisition was obtained 
with a Cell Observer High Speed (Zeiss) microscope equipped with 40x oil Fluar (N.A. 1.3) 
objective. The experiment started with the measurement of the basal level of Ca2+ for at least 
40 cycles and afterwards mitochondrial Ca2+ uptake was induced by 1 mM histamine. Data 
analysis was performed with the software provided by the microscope supplier and to calculate 
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2.2.11. Statistical analyses 
The results were analysed using Microsoft Excel 2013 and GraphPad Prism version 6. For 
Western blotting, all data points represent the mean of at least three independent biological 
replicates. Error bars represent standard errors of the mean unless otherwise stated. For 
confocal images, typically at least 30 cells were analyzed from at least three independent 
experiments; the data indicate average and the error bars represent the standard deviation. 
Differences of means were considered statistically significant for parametric data if they passed 
thresholds calculated as Student’s t-test for two-parameter comparisons. For electron 
microscopy data, all data points represent the mean of at least three independent biological 
replicates. Error bars represent standard errors of the mean. Differences of means were 
considered statistically significant based on Mann-Whitney test. These were indicated as p < 
































3.1. Loss of AMPK activity results in increased endoplasmic reticulum-
mitochondria contact sites 
3.1.1. Mitochondrial function is compromised in AMPK defective cells 
Mitochondria are the major cellular ATP suppliers, promoting the maintenance of energy 
homeostasis, and therefore it is important for the cells to adjust when mitochondria are not 
performing optimally (Mihaylova and Shaw, 2011; Toyama et al., 2016). The AMPK is involved 
in several aspects of mitochondrial biology and homeostasis (Herzig and Shaw, 2018; Kahn et 
al., 2005; Toyama et al., 2016). AMPK signaling is one of the major metabolic pathways activated 
after acute mitochondrial insults, restoring the energy levels by inhibiting ATP-consuming 
pathways or by stimulating catabolic ATP- generating processes (Fernández-Mosquera et al., 
2017; Toyama et al., 2016).  In this sense, in this project we explored if there is an association 
between mitochondrial signaling pathways, which are activated by mitochondrial stress, and the 
regulation of MERCs. For this purpose, mouse embryonic fibroblasts lacking the two catalytic 
subunits of AMPK, α1 and α2 (AMPK α1α2 double knock-out, henceforth AMPK-DKO) were used 
to evaluate if AMPK is involved in the regulation of MERCs, given its essential role in responding 
to mitochondrial malfunctions as described above (Laderoute et al., 2006). In order to 
demonstrate that both AMPK catalytic subunits were lacking, we measured AMPK activity by 
assessing protein levels of AMPK (and phospho-T172 of AMPK, a marker of active AMPK), and 
phosphorylation of ACC pSer79, one of the AMPK targets, by western blot. As expected, we 
observed no phosphorylation of AMPK-T172 and ACC pSer79, indicating no AMPK activity in 
AMPK-DKO (Figure 8a). Moreover, mitochondrial function was also analyzed through the 
evaluation of different parameters, such as, mitochondrial membrane potential, oxygen 
consumption and ROS production. Mitochondrial oxygen consumption rate (OCR) was measured 
under basal conditions and after inhibition or uncoupling oxidative phosphorylation (maximal 
OCR). The AMPK-DKO MEFs showed reduced basal and maximal OCR (Figure 8b-d). Additionally, 
ATP-linked respiration, as well as spare respiratory capacity were reduced in AMPK-DKO cells 
when compared with WT cells (Figure 8e and 8f). Taken together, these results show an 











































Figure 8 | Mitochondrial function is compromised in a defective AMPK cell model. (a) Representative 
immunoblots of AMPK substrates (b) Mitochondrial oxygen consumption rate as assessed by Real Time 
Respirometry (c) Reduced basal mitochondrial OCR in AMPK-DKO MEFs (d) Reduced maximal mitochondrial OCR 
in AMPK-DKO MEFs measured by Real Time Respirometry (e) ATP-linked respiration reduction in AMPK-DKO (f) 
Reduced spare respiratory capacity. Data are representative for three independent measurements. Graphs are 
mean ± SEM for the indicated number of sample replicates and the differences were significant based on the t-






Mitochondrial membrane potential was measured by flow cytometry using JC-1 dye.  This probe 
is a cationic carbocyanine dye that accumulates in mitochondria, and exhibits fluorescence 
emission at two typical wavelengths: (i) red fluorescent J-aggregates (emission maximum at 590 
nm) at high mitochondrial concentrations reflecting higher mitochondrial potential; and (ii) 
green fluorescent J-monomers (emission maximum at ~529 nm) at low mitochondrial 
concentrations indicating loss of membrane potential (Chazotte, 2011; Elefantova et al., 2018). 
In this experiment, subpopulations can be obtained accordingly with the different intensities in 
both channels. Therefore, healthy non-apoptotic cells will be detected in both red and green 
channels, corresponding to the Q2 subpopulation. However, cells with mitochondrial 
dysfunction will have more green intensity, but less red fluorescence, represented as the Q3 
subpopulation in our analysis. From our results, we observed that 12.4% of AMPK-DKO and only 
2.25% of WT cells were in Q3 population, this increase suggests low mitochondrial membrane 
potential (DYm) in AMPK-DKO cells (Figure 9a and 9c). As a positive control, FCCP was used to 
demonstrate increased population of cells with mitochondrial dysfunction (increased green 
fluorescence). This chemical causes a quick mitochondrial membrane depolarization, reducing 









The ETC is a major source of cellular ROS due to the inefficient reduction of molecular oxygen in 
the respiratory chain (Rabinovitch et al., 2017; Valko et al., 2007). Therefore, mitochondrial ROS 
measurement is often used as an indirect parameter to investigate mitochondrial function. In 
this way, mitochondrial ROS production was analyzed by flow cytometry using MitoSOX probe, 

























Figure 9 | AMPK-DKO cells have lower mitochondrial membrane potential. (a)  JC1-monomers vs. JC1-aggregates 
plot for WT cells with JC-1. (b) JC1-monomers vs. JC1-aggregates plot for cells with JC-1 and FCCP, as a positive 
control. (c) JC1-monomers vs. JC1-aggregates plot for AMPK-DKO cells with JC-1 (d) Percentage of WT and AMPK-
DKO cells with positive green signal, represented as Q3 subpopulation. Data are representative for three 
independent measurements. Graph represents mean ± SEM for the indicated number of sample replicates and 







Altogether, these data show that in AMPK-DKO model there is an impairment of mitochondrial 
function. Therefore, we decided to investigate if the mitochondrial morphology was also 
affected in the AMPK-DKO cells. For this purpose, cells were immunostained with TOM20, a 
marker for mitochondria, and several parameters were analyzed, such as mitochondrial area 
and perimeter. From our analysis, no alterations were observed in mitochondrial morphology in 















Figure 10 | MitoSox fluorescence in WT and AMPK-DKO cells, representing mitochondrial superoxide levels. (a) 
Data are representative for three independent measurements. (b) Graph represents mean ± SEM for the indicated 





































Figure 11 | Mitochondrial morphology is not altered in AMPK-DKO. (a) Representative TOM20 immunostainings 
of WT and AMPK-DKO (Scale bar 10 µm). (b and c) Respective mitochondrial morphology analysis of cells in b 
average area per mitochondria and c average perimeter per mitochondria. Data represent mean ± SD of three 
independent experiments.  
 
 
3.1.2. Absence of AMPK activity enhances ER-mitochondria communication in 
mouse embryonic fibroblasts 
ER and mitochondria contact sites are localized in specific regions of the cell, when the 




2006). Therefore, electron microscopy (EM) is required in order to achieve the resolution 
needed to analyze such close contacts. Furthermore, several parameters, such as number of 
contacts and extension, morphological changes of the organelles, can be provided by EM 
(Csordás et al., 2018; Filadi et al., 2018). In this manner, electron micrographs of these cells were 
prepared and used to quantify the number and extension of MERCs (Figure 12a). For this 
purpose, the distance of 30 nm between both organelles was a key criterion to consider 
organelle proximity as a contact site. Representative images are shown in Figure 12a, for which 
281 contacts (n=30 cells) were analyzed in WT cells and 517 contacts in AMPK-DKO cells (n=29 
cells). From the systematic quantification of MERCs, we observed a robust increase of the 
number of MERCs in AMPK-DKO cells (Figure 12b). Additionally, the average perimeter of the 
mitochondria involved in contact sites was decreased in AMPK-DKO cells, suggesting that the 
increase of the number of MERCs is not a consequence of bigger mitochondria (Figure 12c).  
 
 
Figure 12 | AMPK is a negative regulator of ER-mitochondria contact sites. (a) Representative EM images of WT 
and AMPK-DKO MEF (Scale bars, 0.5 µm) (b) Quantification of the number of ER-mitochondria contact sites, in 
which the organelles are separated by less than 30-nm. Data represent mean ± SEM of two independent 
experiments (n >300 mitochondria per experiment). (c) Morphometric analysis of mitochondrial perimeter 





Regarding the length of MERCs, no difference was observed in the average length between 
AMPK-DKO and WT cells (Figure 13a); however longer contact sites were observed in AMPK-
DKO cells (Figure 13b). Taken together, these results suggest that absence of AMPK activity is 




To further validate this result, we transfected cells with GFP targeted to the cytoplasmic side of 
the ER membrane (EGFP-ER) and immunostained the cells with TOM2O for mitochondria and 
obtained confocal images of the cells (Figure 14a). The analysis showed that the overlap 
between the two signals was higher in AMPK-DKOs (Figure 14b). This result suggests an 
increased amount of mitochondria-ER contact sites in the AMPK-DKO cells, in agreement with 
our electron microscopy data. 
 
 
experiment). The differences were significant based on Mann-Whitney test; ***P<0.001; **** P<0.0001; SEM: 
standard error of the mean. 
 
Figure 13 | AMPK -DKO cells have longer contact sites than WT AMPK cells. (a) Morphometric analysis of ER 
length located at less than 30-nm from mitochondria. Data represent mean ± SEM of two independent 
experiments (n >300 mitochondria per experiment) (b) Histogram reporting lengths quantified in (a). SEM: 





Figure 14 | Increased overlap between mitochondria and ER in AMPK-DKOs. (a) Representative confocal images 
of MEFs of the indicated genotype transiently transfected with an ER marker (green) and immunostained with 
TOM20 (red) for mitochondria (Scale bar 10 µm). (b) Quantification of the TOM20 (mitochondria) and TM-Sac1-
GFP (ER) colocalization is shown in (b). Graph represents mean ± SD of three independent experiments and the 
differences were significant based on the t-test; ** P < 0.01.  
 
 
3.1.3. Basal mitochondrial calcium is increased in AMPK-DKO MEFs 
The electron microscopy approach allowed us to investigate the structure of MERCs, however 
this does not take into consideration the dynamics of ER-mitochondria contacts. Therefore, as a 
functional readout we focused on one of the hallmarks of MERCs, which is calcium transfer 
between the organelles (Patergnani et al., 2011). Since we observed an enhancement of the 
number of contact sites in our model of AMPK-DKO, we hypothesized that this effect 
consequently could affect calcium trafficking mediated by MERCs. Thus, we employed a FRET 
probe, whose emission shifts in a Ca2+-dependent manner, as illustrated in Figure 15 (Gibhardt 
et al., 2016; Palmer and Tsien, 2006; Palmer et al., 2006). Furthermore, this strategy is 
advantageous, since it is possible to specifically target this probe to mitochondria, and therefore 














Figure 15 | Schematic illustration of the FRET sensor 4mtD3cpV, targeted to mitochondria and allowing 
mitochondrial Ca2+ measurement. This emission shifts in a Ca2+-dependent manner (Kd = 0.6 µM). 
 
 
For this purpose, AMP-WT and AMPK-DKO cells were transiently transfected with 4mtD3cpv 
(mitochondrial cameleon) followed by live imaging. The basal mitochondrial Ca2+ measured were 
increased in AMPK-DKO cells, which is consistent with the increased number of MERCs observed 





Figure 16 | Mitochondrial calcium is enhanced in AMPK DKO MEFs. (a) Representative fluorescence images of 
AMPK DKO and AMPK WT MEFs transiently transfected with mitochondrial Ca2+ sensor 4mtD3cpV 48h before the 
measurements. Basal mitochondrial Ca2+ levels were recorded in Ringer’s solution containing 0.5 mM Ca2+. (b) 
Quantification of basal mitochondrial Ca2+ in AMPK DKO (140 cells) and AMPK WT (138 cells). Graph represents 






















3.2. AMPK mediates repression of MERCs via MFF 
3.2.1. MFF is an AMPK target and a mitochondria-ER protein 
Given the observed increase in the number of contact sites in the absence of AMPK activity, we 
sought to understand which AMPK targets were in physical proximity of MERCs or played a role 
in their regulation. For this purpose, we crossed a published proteome of MERCs (Hung et al., 
2017) with a list of established AMPK targets (Egan et al., 2011a; Gwinn et al., 2008). We found 
the MFF as the only protein, which scored both as an AMPK target and was localized to the 
MERCs (Figure 17a). This protein is known to be required for mitochondrial fission (Losón et al., 
2013; Otera et al., 2010; Toyama et al., 2016). In order to study the cellular localization of MFF, 
subcellular fractionation experiments of WT and AMPK-DKO MEF were performed. Accordingly, 
MFF is present in ‘crude’ mitochondrial fractions, however the amount of MFF associated with 
the ‘pure mitochondrial’ fraction was robustly reduced in the AMPK-DKO cells while increased 
in the cytoplasm (Figure 17b). Additionally, in AMPK-DKO we can appreciate an increase of 
protein levels of MFN2 and TOM20 in ER fraction, which is in agreement with the increase of 
MERCs observed by EM. As markers for the different fractions, we used TOM20 and VDAC1 for 
the mitochondrial fraction, sec61 beta (ER protein) for the microsomal fraction and finally HPRT 
for the cytosolic fraction (Figure 17b). Taken together, this result suggests that localization of 
MFF in mitochondria is highly regulated by its phosphorylation by AMPK, consistent with the 















Figure 17 | MFF is a MERC-localized AMPK target. (a) Venn diagram showing overlap of AMPK targets with MAM 
proteome. (b) Immunoblots of subcellular fractions of AMPK MEFs subjected to gradient centrifugation. VDAC1 
and TOM20 were used as markers of mitochondria, whereas sec61 beta for ER marker. H, homogenate; CM, crude 




3.2.2. Increased number of MERCs in MFF KO cells  
As mentioned above, MFF was the only protein that scored as being involved in MERCs, as well 
as being an AMPK target. Therefore, to test if MFF is indeed involved in MERCs, we took 
advantage of mouse embryonic fibroblasts lacking MFF (MFF KO) to study MERCs (Liu and Chan, 
2015). Electron microscopy of these cells was performed, and we observed a robust increase in 
the number of MERCs in MFF KO cells (Figure 18a and 18b). Notably, this was not a consequence 
of mitochondrial perimeter changes, since the average perimeter of mitochondria involved in 
MERCS was not different between WT and MFF KO cells (Figure 18c). However, the 
mitochondria not involved in contacts with the ER were significantly bigger in MFF KO, consistent 
with its role in mitochondrial fission.  
 
 
Figure 18 | Increased number of ER-mitochondria contact sites in MFF-KO model. (a) Representative EM images 
of MEFs of the indicated genotype (Scale bars, 0.5 µm) (b) Quantification of the number of ER-mitochondria 
contact sites in which the organelles are separated by less than 30-nm. Data represent mean ± SEM of two 
independent experiments (n >300 mitochondria per experiment). (c) Morphometric analysis of mitochondrial 
perimeter involved in contact sites. Data represent mean ± SEM of two independent experiments (n >300 
mitochondria per experiment). The differences were significant based on Mann-Whitney test. *P < 0.05; SEM: 




Furthermore, the average length of the MERCs was similar in MFF KO and WT (Figure 19a), 
although longer contact sites were mostly observed in MFF KO, similar to the observation in 




3.3. AMPK-dependent phosphorylation of MFF regulates MERCs 
3.3.1. Phosphomimetic MFF Ser155-Ser172 in AMPK-DKO cells has a gain of 
function of MFF  
The obtained results for MFF KO MEFs prompted us to further investigate the role of MFF on 
MERCs. For this reason, we tested if expression of a constitutively active isoform of MFF could 
normalize the increase in MERCs observed in AMPK-DKO MEFs. The outer mitochondria 
membrane protein, MFF, is a DRP1 receptor that triggers mitochondrial fission (Toyama et al., 
2016). In addition, it is known that human MFF has two predicted AMPK phosphorylation sites, 
Ser155 and Ser172 (Figure 20a). In order to investigate the role of the AMPK-MFF axis in the context 
of MERCs, we applied the strategy described by Toyama and colleagues, by expressing WT MFF, 
a non-phosphorylatable Ser155Ala-Ser172Ala (SA2) mutant MFF, as well as, a phospho-mimetic 
Ser155Asp-Ser172Asp mutant (SD2) (Toyama et al., 2016) in AMPK-DKO cells. To prove this 
genetic approach, we took advantage of the fact that MFF is the major receptor for DRP1, and 
 
Figure 19 | MFF KO cells have longer contact sites than WT MFF cells. (a) Morphometric analysis of ER length 
located at less than 30-nm from mitochondria. Data represent mean ± SEM of two independent experiments (n 





is required for mitochondrial DRP1 localization for subsequent mitochondria fission (Losón et 
al., 2013; Otera et al., 2010; Shen et al., 2014; Toyama et al., 2016). Therefore, we verified the 
functional role of MFF overexpression in AMPK-DKO cells using different approaches. We first 
evaluated the phosphorylation of DRP1 S616, which is associated with mitochondrial fission (Ko 
et al., 2016; Liesa et al., 2009; Taguchi et al., 2007). By western blot, we observed equal levels 
of total MFF in all conditions tested (WT MFF, SA2 MFF and SD2 MFF). However, for SD2 MFF 
mutant, we observed an increase in pDRP1 S616 phosphorylation when compared with WT MFF 





Figure 20 | Increase in pDRP1 S616 phosphorylation in SD2 MFF mutant. (a) Schematic representation of MFF 
illustrating location of Drp1-binding domains at amino-terminus and transmembrane domain which localizes MFF 
to outer mitochondrial membrane (b) Protein immunoblot of pDRP1 S616 phosphorylation in AMPK-DKO 
expressing MFF mutants (c) Quantification of immunoblots represented in (b). The differences were significant 




Furthermore, we observed a gain-of-function activity in SD2 MFF mutant in AMPK-DKO MEFs, 
with cells displaying alterations in mitochondrial morphology, such as, shortened mitochondria, 
































Figure 21 | Mitochondrial morphology of AMPK-DKO expressing different MFF mutants. (a) Representative 
immunostainings of TOM20 Mitochondrial morphology of AMPK-DKO + MFF mutants. Cells were stained for TOM20 
(red) and analyzed by confocal imaging (Scale bar 10 µm). (b)  Qualitative analysis of mitochondrial morphology of 









3.3.2. MFF activity normalizes increased MERCs in AMPK-DKO cells  
Our next step was to examine the role of MFF in the remodeling of ER-mitochondria coupling. 
For this purpose, EM was performed on the AMPK-DKO MEFs stably expressing the MFF mutants 
described above, and several parameters to characterize MERCs and mitochondrial morphology 
were analyzed. Electron microscopy revealed that SD2 MFF mutant prevented the increase in 
contacts observed in AMPK-DKO MEFs (Figure 22b). Moreover, morphometric analysis showed 
a decrease in the average perimeter of mitochondria involved in MERCs in AMPK-DKOS with 





Figure 22 | AMPK regulates the number of ER-mitochondria contact sites via MFF. (a) Representative EM images 
of MEFs of the indicated genotype (Scale bars, 0.5 µm) (b) Quantification of the number of ER-mitochondria contact 
sites in which the organelles are separated by less than 30-nm. Data represent mean ± SEM of two independent 
experiments (n >300 mitochondria per experiment).  (c) Morphometric analysis of mitochondrial perimeter involved 
in contact sites. Data represent mean ± SEM of two independent experiments (n >300 mitochondria per experiment).  
The differences were significant based on Mann-Whitney test. *P < 0.05; ***P<0.001; **** P<0.0001; SEM: standard 




Regarding the extension of contact sites between both organelles, we observed an increase in 
length in cells expressing MFF mutants when compared with AMPK-DKO MEFs (Figure 23a and 
23b). Furthermore, when comparing with WT AMPK cells, the AMPK-DKO cells expressing MFF 
mutants still displayed increased extension of MERCs, despite the reduced mitochondrial 
perimeter as described before (Figure 23a and 23b). Taken together, these results suggest that 
AMPK regulates the number of MERCs via MFF phosphorylation. 
 
 
Figure 23 | Increased extension of ER-mitochondria contact sites in AMPK-DKO expressing MFF mutants. (a) 
Morphometric analysis of ER length located at less than 30-nm from mitochondria. Data represent mean ± SEM 
of two independent experiments (n >300 mitochondria per experiment). (b) Histogram reporting lengths 
quantified in (a). SEM: standard error of the mean. The differences were significant based on Mann-Whitney test; 
*P < 0.05; ***P<0.001; SEM: standard error of the mean. 
 
 
3.3.3. Mitochondrial function is improved with MFF genetic manipulation in 
AMPK-DKO cells  
Having demonstrated that MFF has a role in normalizing the increased number of MERCs in 
AMPK-DKO cells, we postulated that this rescue could also have an impact on mitochondrial 
respiration. As a result, oxygen consumption was measured in these cells using seahorse. We 
observed an enhanced OCR in AMPK-DKO expressing WT MFF and mutant SD2 MFF under basal 










3.4. Activation of AMPK decreases mitochondria-ER contact sites 
3.4.1. AMPK activation after acute mitochondrial stress decreases the number 
of mitochondria-ER contact sites 
Taking into account that absence of AMPK activity induces an increase in MERCs, we sought to 
test the opposite, of whether increasing AMPK activity results in a decrease of MERCs in WT MEF 
cells, as a bidirectional effect. Thus, we inhibited the mitochondrial respiratory chain, which we 





























Figure 24 | Mitochondrial function is enhanced in AMPK-DKO expressing MFF mutants. (a) Mitochondrial OCR 
in WT, AMPK-DKO and in AMPK-DKO cells expressing mutant MFF (b) Increased basal mitochondrial OCR in AMPK-
DKO + MFF mutants MEFs as assessed by Real Time Respirometry (c) Increased maximal mitochondrial OCR in 
AMPK-DKO + MFF mutants. Graphs are mean ± SEM for the indicated number of sample replicates and differences 




(Fernandez-Mosquera et al., 2019; Fernández-Mosquera et al., 2017). As such, WT MEFs were 
treated with antimycin A, an inhibitor of complex III of the mitochondrial respiratory chain, for 












Figure 25 | Acute mitochondrial stress activates AMPK signaling. (a) Immunoblots showing the increase of AMPK 
phosphorylation. (b) Band density quantifications from the western blot represented in (a). Graphs are mean ± 
SEM for the indicated number of sample replicates.  The differences were significant based on the t-test, * p < 
0.05. SEM: standard error of the mean. 
 
 
Morphometric analysis using electron microscopy was subsequently carried out, in order to get 
better insights into the effect of acute mitochondrial stress on mitochondria-ER remodeling. For 
this, antimycin A-treated cells were fixed and embedded. Based on analysis of electron 
micrographs (Figure 26a), we observed a striking decrease in the number of MERCs in antimycin-
treated cells (Figure 26b). It is noteworthy that this result was not a consequence of decreased 
mitochondrial perimeter since the average perimeter was increased in mitochondria involved in 






Figure 26 | Acute mitochondrial malfunction decreases the number of ER-mitochondria contact sites. (a) EM 
images of WT MEFs treated during 4h with 10 µM antimycin and ethanol as vehicle control (Scale bars, 0.5 µm) 
(b) Quantification of the number of ER-mitochondria contact sites in which the organelles are separated by less 
than 30-nm. Data represent mean ± SEM of two independent experiments (n >300 mitochondria per 
experiment). (c) Morphometric analysis of mitochondrial perimeter involved in contact sites. Data represent 
mean ± SEM of two independent experiments (n >300 mitochondria per experiment). The differences were 




Additionally, extension of ER involved in MERCs was quantified but no differences were obtained 
between control and antimycin A treatment (Figure 27a), despite an apparent shift towards 
longer contacts as observed by histogram analysis (Figure 27b). Altogether, these results show 
that acute mitochondrial insult, which induces AMPK activation, represses mitochondria-ER 
associations and alters mitochondrial morphology, as demonstrated by decreased number of 
MERCs and increased mitochondrial perimeter, respectively. Moreover, it confirms that AMPK 








3.5. Chronic mitochondrial respiratory chain deficiency results in AMPK 
inhibition and leads to increased mitochondria-ER contact sites 
3.5.1. AMPK activity is repressed in a model of chronic mitochondrial stress 
AMPK signaling is differentially regulated in acute and chronic mitochondrial stress (Fernandez-
Mosquera et al., 2019; Fernández-Mosquera et al., 2017). Therefore, we sought to understand 
if chronic impairment of the respiratory chain affects the associations between mitochondria 
and ER. For this purpose, we used HeLa cells with a lentivirus-delivered stable shRNA targeting 
the complex III subunit UQCRC1 (henceforth, RC-kd) and as control, we used HeLa cells with a 
lentivirus-delivered stable scrambled shRNA (henceforth, scrambled). Two different 
knockdowns of UQCRC1 (RC-kd A and RC-kd B) were prepared in order to evaluate the efficiency 
of each one. This mitochondrial malfunction model was previously characterized by Fernandez-
Mosquera et al, where several parameters associated with mitochondrial function were 
analyzed, including mitochondrial membrane potential, oxygen consumption rate and ROS 
production (Fernandez-Mosquera et al., 2019). This model presents lower oxygen consumption, 
decreased DYm and increased steady-state levels of reactive oxygen species (Fernandez-
Mosquera et al., 2019).  Some of these parameters were again verified and reproduced, 
including the reduced protein levels of UQCRC1 in RC-kd cells and the lower OCR in basal and 
 
Figure 27| Increasing trend of MERCs extension in antimycin A treated cells (a) Morphometric analysis of ER length 
located at less than 30-nm from mitochondria. Data represent mean ± SEM of two independent experiments (n 
>300 mitochondria per experiment) (b) Histogram reporting lengths quantified in (a).  The differences were 




maximal respiration (Figure 28a-d). Furthermore, as previously described, our model of chronic 
mitochondrial malfunction has reduced AMPK activity (Fernandez-Mosquera et al., 2019). 











































Figure 28 | Mitochondrial function is compromised in RC-kd HeLa cells. (a) Immunoblots showing the efficiency 
of a stable knock-down of UQCRC1. (b) Band density quantifications from the western blot represented in (a), (c) 
and (d) Decreased basal mitochondrial OCR in RC-kd cells as assessed by Real Time Respirometry. (e) Immunoblots 
from RC-kd cells and scrambled cells, showing a decrease of MFF protein level. Graphs are mean ± SEM for the 
indicated number of sample replicates. The differences were significant based on the t-test, ** p < 0.01; *** p 




3.5.2. Increased MERCs in chronic mitochondrial malfunction 
In order to investigate whether chronic mitochondrial malfunction has an impact on the MERCs, 
we prepared and obtained electron micrographs of RC-kd cells (Figure 29a). Based on the 
analysis of these micrographs, we observed an increased number of MERCs in RC-kd when 
compared with scrambled cells (Figure 29b). It is important to note that this increase was not a 
consequence of increased mitochondrial length, since the average perimeter of mitochondria 
involved in contact sites was decreased in RC-kd cells (Figure 29c).  
 
 
Figure 29 | Increased ER-mitochondria contact sites in chronic mitochondrial dysfunction. (a) Representative 
EM images of HeLa RC-kd as well as the corresponding control (scrambled) (Scale bars, 0.5 µm). (b) 
Quantification of the number of mitochondria-ER contact sites in which the organelles are separated by less 
than 30-nm. Data represent mean ± SEM of two independent experiments (n >300 mitochondria per 
experiment). (c) Morphometric analysis of mitochondrial perimeter involved in contact sites. Data represent 
mean ± SEM of two independent experiments (n >300 mitochondria per experiment). The differences were 
significant based on Mann-Whitney test, *** p <0.001; **** p £ 0.0001. SEM: standard error of the mean. 
 
 
Regarding the extension of the contact sites analyzed, an increase of the average length was 




slight increase in the length of individual contact sites (Figure 30b). Taken together, these data, 
supported by our previous findings, suggest that increased mitochondria-ER associations in RC-
kd cells could be attributed to the repressed AMPK signaling in this model. 
 
 
Figure 30 | Increased MERC extension in chronic mitochondrial dysfunction. (a) Morphometric analysis of ER 
length located at less than 30-nm from mitochondria. Data represent mean ± SEM of two independent 
experiments (n >300 mitochondria per experiment). (b) Histogram reporting lengths quantified in (a). Data 
represent mean ± SEM of two independent experiments (n >300 mitochondria per experiment). The differences 
were significant based on Mann-Whitney test, **P < 0.01. SEM: standard error of the mean.  
 
 
3.5.3. Increased abundance of MERC related proteins in RC-kd  
Several protein complexes have been established for a long time to be involved in organelle 
appositions of ER and mitochondria. Some examples include MFN2, which is present both in the 
outer mitochondrial membrane and in the ER membranes, and its homodimers keep 
mitochondria tethered to the ER (De Brito and Scorrano, 2008). Moreover, another ER-mito-CS 
complex is formed by the PTPIP51 in the outer mitochondrial membrane and VAP-B in the ER. 
This particular contact site tether has been associated with the regulation of the extension of 
MERCs, since overexpression of either PTPIP51 or VAPB results in increased MERCs extension, 
and their knock-down causes a corresponding decrease (Stoica et al., 2014). Given the crucial 
role of these tethers in MERCs, we evaluated their whole cell protein expression in our model 
of chronic mitochondrial malfunction by western blot. As shown in Figure 31, we observed an 
increase of VAPB and MFN2 protein levels in RC-Kd cell model (Figure 31a and 31b). We 






Figure 31 | Increased protein levels of tethers involved in mitochondria-ER associations in a RC-kd model. (a) 
Immunoblots of whole cell lysates from scrambled and RC-kd cells. HPRT was used as a loading control. (b) Band 
density quantification from the western blot represented in (a). Graphs are mean ± SEM for at least sample 




In addition, since it is the complex between the two components of each ER-mitochondrial 
tethers that is relevant for the MERCs assembly/stability, we tested whether the interaction 
between VAPB and PTPIP51 was affected by immunoprecipitating endogenous VAPB and 
quantifying how much PTPIP51 was associated with it. From our results, we observed an 
increased interaction between both proteins in RC-kd when compared with scrambled cells 
(Figure 32a and 32b). Due to the fact that the immunoprecipitation was performed in whole cell 
extracts, it is possible that we are spuriously including PTPIP51-VAPB interaction that is not 
involved in MERCs. Notwithstanding, it is known that the PTPIP51-VAPB protein complex is 
typically located in MERCs (Stoica et al., 2014; De Vos et al., 2012), accordingly their interaction 
is directly correlated with MERCs. Therefore, this result supports an increased association of 








Figure 32 | Increased interaction of VAPB-PTPIP51 tether complex in RC-kd HeLa cells. (a) Immunoblots 
showing VAPB pull-down, as well as, PTPIP51 interaction in RC-kd and scrambled control. (b) Band density 
quantification from (a). Graphs are mean ± SEM for at least six samples and differences were significant based 
on the t-test, * p < 0.05; SEM: standard error of the mean. 
 
 
3.5.4. Mitochondrial calcium (Ca2+) uptake is enhanced in RC-kd cells 
Since we observed an enhancement of the number of contact sites in our model of 
mitochondrial malfunction, we hypothesized that this effect consequently could affect calcium 
trafficking mediated by MERCs. Thus, we employed the same strategy explained above to 
evaluate mitochondrial Ca2+ transfer. Scrambled and RC-kd cells were transfected with 
4mtD3cpv (mitochondrial cameleon) and followed by live imaging, during which they were 
treated with histamine, a stimulator of IP3Rs, resulting in a release of Ca2+ from ER and 
consequently, increasing mitochondrial Ca2+ uptake at the MERCs.  
The basal levels of Ca2+ measured in mitochondria seemed higher in the RC-kd cells when 
compared with scrambled, which is consistent with the increased number of MERCs observed 
previously (Figure 33a). Since we observed a repression in AMPK signaling in RC-kd, we sought 
to investigate how mitochondrial Ca2+ levels can be modulated by activation of AMPK in RC-kd 
cells. Interestingly, A769662 treatment in RC-kd cells resulted in reduced basal levels of 
mitochondrial Ca2+ when compared to RC-kd cells without treatment (Figure 33a). Furthermore, 
scrambled cells showed a peak of mitochondrial Ca2+ after histamine treatment but RC-kd were 
almost non-responsive to histamine, showing only a residual increase in mitochondrial Ca2+ 
(Figure 33b). This non-responsiveness can be explained by Ca2+ saturation in the RC-kd cells, 
although this premise requires further testing. However, when we activate AMPK signaling in 
RC-kd during 4 hours of treatment with AMPK activator, A769662, we observed a normalization 







Figure 33 | Mitochondrial Ca2+ uptake is enhanced in RC-kd cell model. (a) Quantification of basal mitochondrial 
Ca2+. Data from at least six independent experiments (n ³ 10 recordings per experiment). (b) Mean ± SEM of 
calculated FRET ratio in Ringer’s buffer containing 0.5 mM of Ca2+ where HeLa RC-kd and Scrambled were 
transiently transfected with mitochondrial Ca2+ sensor 4mtD3cpV before the measurements. Cells were also 
treated with 100 µm A769662 or DMSO (as control) during 4h. ER calcium release was stimulated with 1mM of 
histamine at 40 cycles of measurement. The differences were significant based on the t-test, * p < 0.05; **P < 0.01; 
****P < 0.0001. SEM: standard error of the mean. 
 
 
3.5.5. Mitochondrial function is compromised in NDUFS4 KO cells 
In order to support our findings in the chronic mitochondrial model, we also used another 
cellular model with permanent mitochondrial malfunction, NDUFS4 KO. These cells are 
embryonic fibroblasts derived from mice lacking mitochondrial complex I subunit NDUFS4. The 
mitochondrial function in this model was characterized by evaluating mitochondrial respiration, 
ROS production and mitochondrial membrane potential. Mitochondrial membrane potential 
was measured by flow cytometry using JC-1 dye as described above (Figure 34a). As mentioned 
before, for this experiment different subpopulations were obtained accordingly with the 
different intensities in both green and red channels for the JC-1 dye. From our results, we 
observed 10.2% of NDUFS4 KO and only 6.72% of WT cells in the depolarized population (Q3), 
suggesting an increase in the loss of DYm in NDUFS4 KO cells (Figure 34a and b). Furthermore, 
mitochondrial ROS production was also evaluated using MitoSOX probe. We observed an 
increase in the steady state levels of mitochondrial superoxide anion in NDUFS4 KO cells (Figure 




NDUFS4 KO cells. Altogether, as expected, these data support the mitochondrial impairment in 
this model of mitochondrial malfunction. 
 
 
Figure 34 | Mitochondrial function is compromised in NDUFS4 KO model. (a) JC1-monomers vs. JC1-aggregates 
plot for NDUFS4 WT and KO cells with JC-1 dye. (b) Percentage of WT and KO cells with only green positive signal, 
represented as Q3 subpopulation. Data are representative for three independent measurements. (c) Increased 
MitoSox fluorescence in KO cells, which reflects mitochondrial superoxide levels. (d) Decreased basal 
mitochondrial OCR in NDUFS4 KO as assessed by Real Time Respirometry. Graph represents mean ± SEM for the 
indicated number of sample replicates. The differences were significant based on the t-test, * p < 0.05; **P < 0.01; 
****P < 0.0001. SEM: standard error of the mean. 
 
 
3.5.6. Increased MERCs in NDUFS4 KO cell model 
Having established that a chronic model of mitochondrial malfunction (RC-kd cells) has an 
increased number of MERCs relative to the control cells, we decided to test another model of 
chronic mitochondrial malfunction with respect to MERCs using the same parameters as 




morphometric analysis (Figure 35a). We observed an increasing trend in the number of MERCs 
(Figure 35b) and in the perimeter of the mitochondria involved in contact sites with ER (Figure 




Figure 35 | Increasing trend of ER-mitochondria contact sites in NDUFS4 KO cell model. (a) Representative EM 
images of NDUSF4 KO as well as the corresponding control (Scale bars, 0.5 µm). (b) Quantification of the number 
of ER-mitochondria contact sites located at 30-nm maximum distance from outer mitochondrial membrane. (c) 
Morphometric analysis of mitochondrial perimeter involved in contact sites.  
 
 
Taking into consideration the extension of ER in contact with mitochondria, we observed a 
significant reduction of the MERCs length in NDUFS4 KO cells when compared with WT cells 
(Figure 36a). Similarly, the distribution of the length reflected shorter extensions in NDUFS4 KO 











Figure 36 | Increased length of ER in contact with mitochondria in NDUFS4 KO cell model. (a) Morphometric 
analysis of ER length located at less than 30-nm from mitochondria. Data represent mean ± SEM of two 
independent experiments (n >300 mitochondria per experiment). (b) Histogram reporting lengths quantified 

















Nowadays, mitochondrial signaling is not only associated with pathways triggered by 
mitochondria to affect gene expression but also, the response of other organelles to 
mitochondrial signaling, in the context of mitochondrial malfunction, has been recognized 
(Diogo et al., 2018; Fernandez-Mosquera et al., 2019). Reciprocally, the effect of other 
organelles on mitochondrial performance has been described (Peeters et al., 2015; Plotegher 
and Duchen, 2017; Raben et al., 2012; Selak et al., 2000; Yambire et al., 2019). Mitochondria 
interact with other organelles via signaling pathways or by physical interaction. The physical 
interaction between organelles are specialized areas in the cell where organelles directly contact 
each other, which are also known as contact sites (Scorrano et al., 2019). In this thesis, the main 
focus was to study the interaction between mitochondria and ER in the context of mitochondrial 
malfunction, and how these contact sites can be regulated by signaling pathways.  
 
 
4.1. Chronic and acute mitochondrial dysfunction differentially regulate 
MERCs  
Several contact sites have been described, and in the cell mitochondria make contact with 
different organelles, including lysosomes, peroxisomes, ER and lipid droplets (Klecker et al., 
2014; Wong et al., 2018). The ER-mitochondria communication was the first discovered contact 
site, and the most studied organelle interaction, which has also been implicated in several 
cellular functions (Copeland, 1959). However, ER and mitochondria have distinct roles in the 
cell, and therefore for years, the impact of ER and mitochondrial dysfunction at cellular level 
was studied independently. Initially, the physiological role of MERCs was more associated with 
lipid transfer and calcium exchange between the two organelles (Kornmann et al., 2009; Rizzuto, 
1998; Rizzuto et al., 2009). However, in the past several decades, with a growing interest in this 
field, the multifaceted role of MERCs in different cellular processes were discovered, and this 
role has been extended to new aspects of mitochondria and ER dynamics and function, such as 
active trigger of mitochondrial constriction and its subsequent division (Friedman et al., 2011). 
Given the molecular complexity of mitochondria-ER interface, it is plausible to hypothesize its 
implication in key signaling pathways, including the ones, which are activated after a 





In this study, as models of chronic mitochondrial malfunction, we used a stable knockdown of 
UQCRC1, a nuclear-encoded component of mitochondrial complex III, in HeLa cells, as well as 
MEFs from the NDUFS4-KO mouse with a deletion of one of the subunits of complex I of the ETC. 
These proteins are involved in the complex formation, and their deficiency leads to a failure in 
the proper formation of the complexes  (Diaz et al., 2011; Gaspar et al., 2019). As expected, and 
also described previously by us, both models presented here have an impairment of 
mitochondrial performance, such as, loss of mitochondrial membrane potential and less oxygen 
consumption in basal and maximal respiration (Fernandez-Mosquera et al., 2019). Despite being 
an indirect measure of mitochondrial function, an increase of ROS production was observed, as 
also described in other cellular models associated with mitochondrial dysfunction (Lin and Beal, 
2006; Wang et al., 2014). Notably, despite the different mutations in the respiratory chain 
complexes, an enrichment of MERCs was observed in both models of chronic mitochondrial 
malfunction. This finding underscore that changes in the number of MERCs due to chronic 
mitochondrial dysfunction are likely independent of the affected respiratory chain complex. 
Notwithstanding, other parameters analyzed, such as mitochondrial perimeter and length of 
MERCs, were not consistent in both models. This outcome suggests that complex-specific 
defects persist, given the localization of the defective proteins to different mitochondrial 
respiratory chain complexes, which can impact mitochondrial signaling and performance 
differently. 
 
The ER-mitochondria communication is pivotal for the regulation of cellular homeostasis as well 
as, mitochondrial function. In fact,  the key role of MERCs in the regulation of Ca2+ signaling, and 
consequently the impact on mitochondrial metabolism, bioenergetics and cell survival has been 
strongly established (Bravo-Sagua et al., 2017; Cárdenas et al., 2010; Rizzuto, 1998). Indeed, we 
show here an increase in basal mitochondrial Ca2+ in RC-kd cells. Therefore, the increase of 
MERCs can be a strategy of mitochondria to keep their functions by improving the Ca2+ transfer 
to mitochondria. For instance, the Ca2+ that is transferred to the mitochondria from ER allows 
the activation of some enzymes associated with TCA cycle, thus improving ATP production 
(Denton, 2009; Rossi et al., 2019). More recently, Ca2+ was also reported to modulate the ETC 
and F1F0 ATP synthase, supporting an important role of Ca2+ on mitochondrial metabolism 
(Glancy et al., 2013; Rossi et al., 2019; Territo et al., 2017). However, it is important to mention 
that despite the enrichment of MERCs, an improvement in mitochondrial performance was not 
observed. This likely due to persistence of the mitochondrial dysfunction as the effects of a 




increase, thereby making it less likely to see an improvement, similar to wild type levels, in 
mitochondrial function. Nevertheless, it is conceivable that MERCs enrichment is linked with a 
beneficial effect for mitochondria and consequently for the fate of the cell.  
Furthermore, an increase of MERCs was also observed in some disease models in which 
mitochondrial function is also impaired as a consequence of the pathology (Arruda et al., 2014). 
Furthermore, alterations in MERCs formation in some neurodegenerative disorders, such as 
Alzheimer’s disease has been shown (Area-Gomez and Schon, 2016; Hedskog et al., 2013; 
Schreiner et al., 2014). 
In addition, to verify if the findings described pertained to only chronic mitochondrial 
malfunction, we employed a model of acute mitochondrial stress, by treating cells with 
antimycin A, a potent inhibitor of complex III of the ETC. EM analysis revealed that acute 
mitochondrial stress negatively affects the interaction between mitochondria and ER, observed 
by the reduction of the number of MERCs. Noteworthy, the decrease observed in the number 
of contact sites between mitochondria and ER was not a consequence of reduced mitochondrial 
perimeter since the average perimeter was increased in mitochondria involved in MERCs. One 
plausible explanation for this different outcome might be that the adaptive mechanism of 
increasing the number of MERCs and consequently improving mitochondrial performance is a 
long-term process. Hence, given the sudden and short duration of the mitochondrial stress in 
acute mitochondrial malfunction, it is likely that this adaptive mechanism is not triggered, and 
other pathways of improving mitochondrial function are engaged. Altogether, these findings 
underscore that the process of MERCs formation indeed responds to cellular signaling 
mechanisms and the regulation of MERCs responds differentially to mitochondrial stress 
depending on whether the stress is acute or chronic. 
 
 
4.2. AMPK signaling is regulated differentially in chronic and acute 
mitochondrial stress  
In the cell, the majority of ATP generation occurs in mitochondria, the sites of oxidative 
phosphorylation (Herzig and Shaw, 2018). Furthermore, it is important for the cells to manage 
their energy consumption depending on the nutrient availability, and on their capability to 
produce ATP. In some situations, ATP levels can decrease in the cell, making it essential for the 
cells to minimize energy consumption. In addition, under these conditions, processes aimed at 




energy, need to be employed (Herzig and Shaw, 2018). In higher eukaryotes, AMPK is a key 
player in a system, which allows the modulation of cellular metabolism depending on nutrient 
availability (Herzig and Shaw, 2018). AMPK activation promotes catabolism and decreases 
anabolism by phosphorylation of key proteins involved in multiple pathways, thereby restoring 
energy balance (Herzig and Shaw, 2018). Some aspects of mitochondrial biology and 
homeostasis are regulated by AMPK, such as stimulation of mitochondrial biogenesis, regulation 
of mitochondrial network, and regulation of mitochondrial quality control via regulation of 
autophagy and mitophagy (Kahn et al., 2005; Mihaylova and Shaw, 2011; Toyama et al., 2016). 
Moreover, it is known that AMPK is acutely induced under mitochondrial respiratory chain 
inhibition (Fernandez-Mosquera et al., 2019; Fernández-Mosquera et al., 2017; Herzig and 
Shaw, 2018).  
Remarkably, in our model of chronic mitochondrial dysfunction (RC-kd), the AMPK pathway is 
repressed, which we previously observed in the context of another study (Fernandez-Mosquera 
et al., 2019). Besides, being a counterintuitive result, an explanation can be due to the increased 
protein levels of folliculin (FLCN) and folliculin interacting protein 1 (FNIP1) in the same model 
of chronic mitochondrial malfunction (Fernandez-Mosquera et al., 2019). Indeed, FLCN is a 
tumor-suppressor, and so far it is the only protein that is able to inhibit AMPK activity by forming 
heterotrimer complexes with FNIP1 and FNIP2 (Yan et al., 2014). On the other hand, and 
consistent with previous findings, our acute mitochondrial model displayed increased AMPK 
signaling. Indeed, using the same complex III inhibitor as in this study, Toyama and colleagues 
also reported AMPK activation in U2OS osteosarcoma cells, where extensive mitochondrial 
fragmentation was also detected (Toyama et al., 2016) further highlighting that AMPK activation 
following acute mitochondrial stress in independent of the cell type. 
 
Interestingly, it can be appreciated from the findings that AMPK activity negatively correlates 
with the enrichment of MERCs. In chronic mitochondrial malfunction, the enrichment of MERCs 
is associated with repressed AMPK activity. Contrarily, acute mitochondrial stress is associated 
with increased AMPK activity and decreased number of MERCs. Taken together, this suggests 









4.3. AMPK negatively affects MERCs formation 
As mentioned above, there is a relation between mitochondrial malfunction and the activation 
of AMPK signaling. Hence, to test if AMPK is indeed involved in the regulation of MERCs, we 
employed mouse embryonic fibroblasts lacking the two isoforms of the catalytic subunit of 
AMPK, α1 and α2 (AMPK α1α2 double knock-out) (Laderoute et al., 2006). Several studies 
reported adaptive mechanisms in AMPKα1-/- and AMPKα2-/- mice by upregulation of the 
remaining AMPKα isoform, thus restoring and improving the response to metabolic stress 
(Jørgensen et al., 2004; Lieberthal et al., 2013). Consequently, it was crucial to develop a full 
AMPKα KO model in order to avoid this possible compensatory effect (O’Neill et al., 2011).  
 
Our EM and fluorescence data suggested that the absence of AMPK activity is associated with 
increased amount of MERCs, demonstrating the negative regulation of AMPK on MERCs 
remodeling. This result was not due to changes in mitochondrial morphology or perimeter, since 
no morphological alterations were observed in cells lacking AMPK activity. The apparent effect 
of AMPK on mitochondria-ER communication can be seen as a strategy to keep both organelles 
far away from each other. Due to the robust catabolic response of cells to AMPK activation, it 
would be beneficial to move mitochondria elsewhere, since the proximity of mitochondria to 
ER, either due to the physical association or localization within the cell, can have negative effects 
on mitochondrial performance. In fact, it is known that in some conditions, such as in 
hepatocytes from obese mice, an increase of MERCs is associated with mitochondrial Ca2+ 
overload and higher mitochondrial ROS production. These effects were ameliorated by silencing 
PACS2 and IP3R1 (Arruda et al., 2014), suggesting that the higher proximity of mitochondria to 
ER could negatively impact mitochondrial performance. Additionally, these findings support the 
importance of tightly regulating MERCSs for the control of functional interactions between 
mitochondria and ER. Moreover, the increase of the number of MERCs was consisting with a 
slight increase on mitochondrial Ca2+ levels in AMPK-DKO cells, which could suggest that the 
effect observed is more structural than functional. In fact, it is known the ER plays a role by 
marking the possible constriction sites in mitochondria for fission (Friedman et al., 2011), thus 
contributing spuriously to the increase of functional MERCs until the fission process is 
completed. Additionally, a close relation between AMPK and the mitochondrial fission is known, 
since this kinase is able to activate some of the mitochondrial fission factors (Ducommun et al., 
2015; Toyama et al., 2016). Altogether, cells lacking AMPK have repressed mitochondrial fission, 
suggesting the continued presence of ER close to mitochondria, which results in an increase of 








4.4.  The effect of AMPK on MERCs regulation is mediated by MFF 
In order to understand the mechanism of how AMPK regulates MERCs, we reasoned that an 
AMPK target must play a crucial role in MERCs. Here, we found out that MFF fits such a target 
since it was the only protein that scored after crossing published publicly available data sets of 
AMPK targets (Egan et al., 2011b; Gwinn et al., 2008) and MAM proteome (Hung et al., 2017). 
MFF localizes to mitochondria, where it functions as a receptor for DRP1, which catalyzes 
membrane scission during the process of mitochondrial fission (Losón et al., 2013; Otera et al., 
2010; Shen et al., 2014; Toyama et al., 2016). In fact, in our subcellular fractionation results, we 
confirmed the presence of MFF in mitochondrial fractions. Interestingly in ‘pure mitochondrial’ 
fractions its amount was robustly decreased while increased levels were observed in the 
cytoplasm in AMPK-DKO cells. Altogether, this suggests that MFF phosphorylation by AMPK is 
required for its localization to mitochondria. Consistently, it was proved that the participation 
of MFF in mitochondrial fission is highly regulated by AMPK (Toyama et al., 2016). Notably, we 
found an enrichment of MERCs in cells lacking MFF-KO, providing evidence that MFF indeed is 
involved in repressing MERCs formation. Remarkably, the average mitochondrial perimeter of 
those involved in MERCs was not changed. 
 
The elegant study from Toyama and colleagues demonstrated the role of AMPK on 
mitochondrial fission via its activity on MFF (Toyama et al., 2016). We took advantage of the 
remarkable manipulation of MFF phosphorylation in this study to elucidate how AMPK activity 
is coupled to MFF in remodeling MERCs, by expressing WT MFF, a non-phosphorylatable 
Ser155Ala-Ser172Ala (SA2) mutant MFF, as well as, a phospho-mimetic Ser155Asp-Ser172Asp 
mutant (SD2) in AMPK-DKO cells. Consistent with the previous study, the SD2 MFF mutant 
displayed gain-of-function activity when introduced into AMPK-DKO MEFs, displaying shortened 
mitochondria comparable with those expressing WT MFF (Toyama et al., 2016). 
In the context of MERCs, our EM data shows that the phospho-mimetic isoform of MFF (SD2 
MFF) normalizes the mitochondria-ER contact sites in cells lacking AMPK activity, suggesting that 
the effect of AMPK on MERCs is mediated by MFF. This result is consistent with the idea that the 
increased number of MERCs observed due to genetic absence of AMPK or absence of AMPK 




MFF activity prevents the increase in contacts observed in AMPK-DKO MEFs, this effect might 
suggest that the re-activation of the mitochondrial fission process by more interaction of DRP1 
with MFF completes the mitochondrial fission, thus minimizing the requirement for ER contacts 
to mark constriction sites on mitochondria. 
Previously, the role of MERCs on mitochondrial fission was shown, in which ER tubules wrap 
around mitochondria to mark the fission sites (Friedman et al., 2011; Murley et al., 2013). 
Remarkably, MFF also localizes in these constriction regions to mark the sites where DRP1 will 
be recruited in order to trigger membrane scission (Friedman et al., 2011). From our data, we 
conclude that MFF seems to be involved in both mitochondrial fission and contact sites. In the 
absence of or diminished AMPK signaling, or when MFF is removed, mitochondrial fission is 
repressed, resulting in an increased proportion of long mitochondria. It seems the AMPK-MFF 
axis tightly regulates to linked processes: mitochondrial fission and from our data mitochondria-
ER contact sites. Notwithstanding, this study could not establish a direct role of AMPK as a 
structural tether between both organelles. However, it is also important to keep in mind that it 
is rather difficult to appreciate the role of a single tethering pair or molecule in remodeling 
MERCs. This is likely due to the large list of tethering proteins, which have been discovered to 
be associated with MERCs (Hung et al., 2017) and further justified by the findings that it is 
virtually impossible to eliminate a contact just by deleting any tether pair (Scorrano et al., 
2019). Despite these limitations, here we demonstrated that signaling pathways are able to 
regulate MERCs, in particular AMPK via MFF. 
 
Taken together, it seems that the association of mitochondria with the ER is another aspect of 
mitochondrial biology that is regulated by AMPK. The importance of AMPK in cell metabolism is 
very well characterized. For instance, AMPK is known to play a role in the upregulation of genes 
involved in mitochondrial biogenesis in the presence of mitochondrial dysfunction (Garcia-Roves 
et al., 2008; Herzig and Shaw, 2018; Jager et al., 2007) or to promote mitochondrial quality 
control via the removal of damaged mitochondrial through its regulation of the autophagy 
process (Egan et al., 2011a; Mihaylova and Shaw, 2011). However, in our model of chronic 
mitochondrial malfunction AMPK activity is repressed, and thus unable to activate adaptive 
mechanisms to improve mitochondrial quality. Therefore, it seems rational that the lack of 
AMPK will be couple to the regulation of a mechanism of increasing MERCs in the chronic 
mitochondrial model, as “backup” mechanism to increase mitochondria performance. 
Consistently, the acute mitochondrial stress model, which activates AMPK signaling, is likely able 




require this “backup” mechanism, leading to its suppression. In a recent paper from our group, 
using the same model of chronic mitochondrial malfunction, defects in lysosomal function and 
consequently impaired autophagy as a consequence of mitochondrial dysfunction (Fernandez-
Mosquera et al., 2019) were observed. These findings suggest that maintenance of 
mitochondrial quality via mitophagy was impaired and highlight the crucial need for a 
mechanism to increase mitochondrial function to support survival. The increase of MERCs via 



























5. Summary and conclusion 
Eukaryotes have a distribution of cellular functions in organelles, including the nucleus, 
mitochondrion, ER, or lysosomes. The existence of inter-organelle communication, as well as its 
role in several cellular functions, is becoming clear. In addition, organelle interplay is essential 
to maintain organelle homeostasis, and contributes to some pathologies that arise with 
organelle malfunction. Thus, understanding the crosstalk between organelles is a timely aspect 
of cell biology. During several years the impact of mitochondrial and ER dysfunction in the cell 
was studied independently due to the distinct primary roles of these organelles in the cell. 
Nevertheless, their interaction and capability to regulate the functions of each other has been 
recognized for decades. Furthermore, the effects of mitochondrial signaling, in the context of 
mitochondrial dysfunction, on other organelles has been described. Reciprocally, how defects 
in other organelles affect mitochondrial performance has also been characterized. However, 
evidence of how mitochondrial dysfunction can affect MERCs is little. 
  
The outcomes of this study broaden our understanding of the mechanisms of communication 
between mitochondria and ER, in a context of mitochondrial dysfunction. This thesis addresses 
the effect of mitochondrial malfunction, in particular from respiratory chain stress, on MERCs 
formation and function. Here, it was shown that acute and chronic mitochondrial malfunction 
stresses have differential outcomes on MERCs formation. Interestingly, the AMPK signaling node 
seems to be the most important pathway mediating the MERCs formation in the context of 
mitochondrial malfunction. Moreover, AMPK responses differentially for the different 
mitochondrial malfunction stresses. In fact, the AMPK regulation seems to be dependent by MFF 
activity, since we observed that modulation of MFF activity in cells lacking AMPK restores the 
number of MERCs. Hence, we show here that AMPK is a negative regulatory kinase of the MERCS 
formation via the action of MFF (Figure 37). 
 
To conclude, our findings reveal that MERCs respond to mitochondrial respiratory chain 
malfunction in a defined manner through a well-understood signaling pathway, which may 










Figure 37 – Proposed model of mitochondria-ER communication in chronic and acute mitochondrial stress. AMPK 
responds differentially to the different mitochondrial malfunction stresses, (A) chronic mitochondrial malfunction 
and (B) acute mitochondrial dysfunction. AMPK regulation of MERCs seems to be dependent on MFF activity. 
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